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Introduction
Introduction
Up to 1991 several families suffering from an autosomal stroke condition of 
unknown aetiology were reported under various names such as “hereditary 
multi-infarct dementia”, “chronic familial vascular encephalopathy”, 
and “familial disorder with subcortical ischemic strokes, dementia, and 
leukoencephalopathy”1-5. Because of the confusion raised by all these different 
names, the acronym of CADASIL (Cerebral Autosomal Dominant Arteriopathy 
with Subcortical Infarcts and Leukoencephalopathy) was proposed by a 
French research group in the early 1990s following discovery of the underlying 
mutation that many of the earlier described families had in common6-9.
CADASIL is an autosomal dominant disease characterized by migraine, 
recurrent stroke, and progressive cognitive impairment. This disease is caused 
by mutations in the NOTCH3 gene, located on chromosome 19.
In this introductory chapter a summary of the major clinical, genetic, 
pathological, and radiological aspects of CADASIL will be given and the aims 
of this thesis will be described.
Clinical aspects of CADASIL
The initial clinical symptoms of CADASIL vary both between and within 
affected families. Symptoms of this disorder appear from the mid-twenties to 
around 45 years of age and affected individuals typically die before the age 
of 6510.
The most common clinical presentation of CADASIL is the presence of 
recurrent subcortical ischemic events, which occur in 80% of all patients with 
a mean age of onset varying from 41 to 49 years. In the early phase of the 
disease, symptoms are often mild and transient, resembling transient ischemic 
attacks8,10,11. 
The second most common feature in CADASIL patients is the development of 
cognitive defi cits. Dementia is found in 60% of patients by the age of 45, and 
in 90% before death10. It is characterised by memory impairment and is usually 
associated with pseudobulbar palsy, gait disturbances, sphincter incontinence 
and pyramidal signs8. It seems that cognitive decline of CADASIL patients can 
progress in two different ways: a stepwise deterioration due to successive 
strokes, or the gradual development of a pseudobulbar syndrome12.
Thirty-fi ve percent of CADASIL patients have attacks of migraine with aura. 
Migraine with aura  is the earliest clinical manifestation, occurring at a mean 
age of 268,10,11,13. The prevalence of this type of migraine in the general 
population is about 6%14. However, this symptom should suggest a diagnosis 
of CADASIL only when associated with white matter hyperintensities (WMHs) 
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on cerebral magnetic resonance (MR) imaging. Remarkably, CADASIL 
patients often develop migraine attacks shortly before or after their fi rst stroke, 
suggesting the occurrence of similar pathophysiological events in CADASIL 
and migraine12.
Mood and psychiatric disturbances, including severe depression, sometimes 
with alternating manic episodes, have been observed in 30% of patients with 
CADASIL8,10,11. Like migraine, mood disorders should suggest a diagnosis of 
CADASIL only when associated with diffuse WMHs on cerebral MR imaging. 
Epileptic insults are present in up to 10% of the CADASIL patients and probably 
are secondary to cortical damage8,10,11.
A small number of CADASIL patients may experience an encephalopathic 
illness characterised by a period of impaired consciousness and neurological 
abnormalities usually recovering after about two weeks15-17.
Genetic aspects of CADASIL
In 1993 CADASIL was linked to chromosome 199,18. In 1996, mutations in NOTCH3 
gene were found19. Until now 54 different mutations have been reported20. 
The highly conserved Notch signalling pathway was originally identifi ed and 
studied in the fruit fl y Drosophila melanogaster. The name “Notch” derives 
from the characteristic notched wing found in fl ies carrying only 1 functioning 
copy of the gene. Homozygous NOTCH3 mutations in fruit fl y are lethal, and 
affected embryos have severe abnormalities, including an excess of neural 
cells21. The Notch signalling appears to function as a general development 
tool, essential for proper embryonic development in species ranging from 
insects to mammals. The exact mechanism whereby defects in the NOTCH3 
protein cause the vasculopathy of CADASIL remains to be determined. In 
CADASIL, all mutations in NOTCH3 are the loss, or gain of a cysteine residue. 
Mutation analysis for diagnostic purposes is possible22. As intervention to 
prevent or delay onset age or even change the clinical course of CADASIL is 
not routinely possible, presymptomatic DNA testing in CADASIL families should 
be done with caution. DNA testing should be accompanied by genetic 
counselling, informing the patient and his/her family about the course of the 
disease and the risk of transmitting the abnormal gene to their offspring’s23,24. 
Obviously, attention should be paid to psychological reactions such as denial 
and minimisation in gene carriers and survivor guilt in non-mutation carriers. 
Histopathological aspects of CADASIL
Post mortem studies of affected patients show multiple small infarcts and 
leukoencephalopathy throughout the subcortical white matter as well as in 
the basal ganglia and thalamus2,3,7,25.
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The characteristic histological fi nding is a vasculopathy of small and middle-
sized arterioles. Smooth muscle cells of the media are replaced with deposits 
of basophilic granular electron-dense material known as granular osmiophilic 
material (GOM) resulting in destruction of vascular smooth muscle cells and 
fi brous thickening of the arterial wall7,26.
It is believed that these GOM depositions in the blood vessel wall result in 
both reduced blood fl ow and an inability of the blood vessels to regulate 
blood fl ow (cerebrovascular reactivity), causing WMHs and lacunar infarcts. 
Cerebrovascular reactivity refl ects the compensatory dilatory capacity of 
cerebral arterioles to a stimulus such as carbon dioxide or acetazolamide. 
In elderly individuals impaired cerebrovascular reactivity is associated with 
WMHs and lacunar infarcts27-29. In patients with CADASIL, alterations in cerebral 
blood fl ow and cerebrovascular reactivity have also been demonstrated, with 
a signifi cant reduction in baseline cerebral blood fl ow and cerebrovascular 
reactivity in areas of WMHs30-33. From these observations, however, cannot be 
derived whether structural brain changes are secondary to impaired fl ow, or 
whether impaired fl ow is a consequence of brain damage.
Although in CADASIL abnormalities in blood vessels can be found throughout 
the body, they appear to be most severe in the brain. The vasculopathy 
in the brain gives rise to the characteristic clinical signs and symptoms in 
CADASIL patients. The reason for the brain being the site of predilection is still 
unknown34. 
The diagnosis of CADASIL can be confi rmed by electron microscopic (EM) 
analysis of the arterioles in a skin biopsy35,36. Although the identifi cation of 
characteristic vascular abnormalities (GOM in the media) is highly specifi c for 
CADASIL, these abnormalities are not always found. The false negative rate of 
skin biopsy analysis fi nding is unknown37,38.
Radiological aspects of CADASIL
Two types of lesions have been described in patients with CADASIL. The fi rst 
type are WMHs, symmetrically distributed and located in the periventricular 
and deep white matter39. There is a relative sparing of the arcuate fi bers and 
cortex40. The WMHs are predominantly localized in the frontal lobe, followed 
by the temporal and parietal lobes. The occipital lobe is markedly less severely 
affected41,42. It has been demonstrated that the external capsules and 
(anterior) temporal lobes are also sites of predilection for WMHs43. Brain stem 
white matter abnormalities, located mainly in the pons and mesencephalon, 
are also frequently observed, while involvement of the cerebellum appears
Chapter 1
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to be very uncommon39,44. In symptomatic patients MR imaging of the brain is 
always abnormal, however WMHs have also been detected in asymptomatic 
NOTCH3 mutation carriers45. 
The second type of lesions are lacunar infarcts in the centrum semiovale, 
thalamus, basal ganglia and pons40. The prevalence of both WMHs and 
lacunar infarcts increase with age. 
There are several ways to detect in vivo microscopic damage that remains 
undetected using conventional radiological techniques. Studies using diffusion 
tensor imaging, magnetization transfer imaging and MR spectroscopy in 
CADASIL have shown that microstructural changes are present in both 
normal and abnormal white matter, probably refl ecting neuronal loss 
and demyelination46-48. Also, they found that the degree of the underlying 
ultrastructural alterations is related to the clinical severity. 
Differential diagnosis
The differential diagnosis of CADASIL depends upon the age of the patient. 
The diagnosis of CADASIL is often made at a young age and the recurrence of 
multifocal neurological defi cits with relative young age-of-onset, and WMHs 
on MR imaging that are initially patchy makes it diffi cult to distinguish CADASIL 
from multiple sclerosis (MS)49,50. Another differential diagnostic consideration of 
CADASIL, based on the radiological picture, is mitochondrial encephalopathy 
with lactic acidosis (MELAS). However, this disease is readily distinguished from 
CADASIL on the basis of a familial pattern suggestive of maternal inheritance, 
clinical features, or supplementary tests. Binswanger’s disease, a rare form of 
dementia characterized by loss of memory and cognition, mood changes, 
and abnormal blood pressure, should be considered in older patients because 
of the confl uent WMHs and lacunar infarcts. However, a history of severe long 
lasting hypertension is often lacking in CADASIL patients, there is no familial 
occurrence in Binswanger’s disease and the age of onset in Binswanger’s 
disease is usually later. 
Purpose and outline of the thesis
The discovery of the mutations in the NOTCH3 gene in 1996 was an important 
landmark in CADASIL research since it provides a reliable confi rmation of the 
clinical diagnosis. At the Leiden University Medical Centre (LUMC) a study 
was started on the clinical, radiological, pathological, neuropsychological, 
and genetic aspects of CADASIL patients in the Netherlands. Members of 
15 unrelated Dutch CADASIL families were asked to participate in this study. 
Index patients identifi ed through NOTCH3 mutation analysis were referred from 
various medical institutions to the LUMC, which serves as a national CADASIL 
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referral centre. The total number of participants was 63 of which 41 turned out 
to be mutation carrier and 22 were not. The advantage of this study set-up 
was that the asymptomatic family members were unaware of their genetic 
status and a representative control group for the mutated family members 
was built into the study. The studies that are described in this thesis are based 
on material that was generated in the Dutch CADASIL study.
The purpose of this thesis is to refi ne the morphological phenotype of cerebral 
abnormalities in CADASIL using MR imaging. A diagnosis of CADASIL cannot be 
made without MR imaging. Recognizing the MR imaging features of CADASIL 
can help to increase the chance of detecting CADASIL by genetic screening 
and distinguish this largely underdiagnosed disorder from similar conditions 
associated with WMHs such as aging, Binswanger’s disease, MELAS, and MS. 
In this thesis we also evaluated the infl uence of potential risk factors and the 
effect of the vessel wall pathology on the structural MR lesions. 
This thesis addresses the following study objectives:
1) Are cerebral vessels in CADASIL patients more prone to bleed as expressed 
by the presence of microbleeds? 
2) Is there a relation between the amount of microbleeds and disease 
severity?
3) What is the prevalence and distribution of a type of lacunar lesions that, 
to our knowledge, has not been described before in the neuroimaging 
literature in neither CADASIL patients nor in patients with other disorders?
4) What is the typical appearance of MR imaging abnormalities in CADASIL 
and does this differ and progress per age category?
5) What are the clinical, neuropsychological and radiological features of 
CADASIL patients under the age of 35 years?
6) Is it possible to distinguishing CADASIL patients from MS patients on the 
bases of the radiological hallmarks of CADASIL?
7) What is the infl uence of apolipoprotein E genotype on the development 
of radiological abnormalities in CADASIL patients?
8) Is a decrease in cerebral blood fl ow or cerebrovascular reactivity primarily 
responsible for the development of WMHs and lacunar infarcts?
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Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL) is a hereditary arteriopathy 
leading to recurrent cerebral infarcts and dementia. Intracerebral 
haemorrhage (ICH) has been described sporadically in patients with 
CADASIL, suggesting that the affected arteries in CADASIL are not 
bleed-prone. However, the presence of cerebral microbleeds, which 
often remain undetected on conventional magnetic resonance 
(MR) imaging, has not been determined in CADASIL. Purpose was 
to determine whether cerebral vessels in patients with CADASIL are 
prone to microbleeding.
T2*-weighted gradient echo MR imaging, which is highly sensitive 
for visualizing microbleeds, was performed in patients with CADASIL 
and their family members (n=63). Known risk factors for ICH were 
determined for all individuals. On an exploratory basis, the presence 
of cerebral microbleeds was correlated with demographic variables, 
vascular risk factors, disease progression, ischemic MR lesions, and 
genotype.
Cerebral microbleeds were present in 31% of symptomatic CADASIL 
mutation carriers, predominantly in the thalamus. Vascular risk factors 
such as hypertension did not account for the microbleeds in these 
patients. Factors associated with microbleeds were age (P=0.008), 
Rankin disability score (P=0.017), antiplatelet use (P=0.025), number 
of lacunae on MR images (P=0.009), and the Arg153Cys NOTCH3 
mutation (P=0.017). After correction for age, only the Arg153Cys 
mutation remained signifi cantly associated with the presence of 
microbleeds.
Patients with CADASIL have an age-related increased risk of 
intracerebral microbleeds. This implies that they may have an 
increased risk for ICH, which should be taken into account in CADASIL 
diagnosis and patient management.
19
Cerebral microbleeds in CADASIL
Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is a hereditary small-vessel disease caused 
by mutations in the NOTCH3 gene on chromosome 1919. Clinically, the disease 
is characterized by recurrent cerebral infarcts and dementia, and patients 
may also experience migraine or affective disorders. Magnetic resonance 
(MR) imaging reveals extensive cerebral white matter lesions and subcortical 
infarcts. On pathologic examination, there are marked changes in the small 
cerebral arteries with thickening of the media, loss of vascular smooth muscle 
cells, and accumulation of extracellular nonamyloid, noncholesterol, electron-
dense granular material51.
Primary intracerebral haemorrhage (pICH) has rarely been described in 
CADASIL, in contrast to other small-vessel diseases associated with white 
matter changes and infarcts, including hypertensive lipofi brohyalinosis and 
cerebral amyloid angiopathy (CAA)52-54. This discrepancy could indicate that 
CADASIL vessels, though thickened, are not fragile and thus do not lead to 
pICH or that CADASIL patients with pICH remain unrecognized. In the last 5 
years, a strong association has been found between ischemic small-vessel 
disease and the presence of cerebral microbleeds detected on T2*-weighted 
gradient echo MR images54-57. This is a highly sensitive technique to detect 
haemosiderin deposits and thus remnants of intracerebral microbleeds, which 
are clearly visualized as small areas of signal loss56. Microbleeds in a randomly 
selected elderly population occur in 6.4% of individuals and are related to 
other indicators of small-vessel disease, whereas up to 26% of patients with a 
history of ischemic stroke have microbleeds55,58. Determining the presence of 
microbleeds in patients with CADASIL could answer the question of whether 
intracerebral extravasation of blood occurs in CADASIL arteriopathy. If so, this 
may implicate an increased risk of pICH in patients with CADASIL.
We sought to determine whether cerebral microbleeds occur in individuals 
with a confi rmed NOTCH3 mutation and, if so, whether the presence of 
microbleeds is associated with other patient characteristics such as severity 
of concomitant MR lesions, vascular risk factors, and genotype.
Materials and methods
Subjects
Members of 15 families with CADASIL were asked to participate in a clinical and 
genetic study on CADASIL. For all families, the respective NOTCH3 mutation 
had previously been determined in at least one clinically affected member. 
Symptomatic as well as asymptomatic family members were included in the 
Chapter 2
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study. Participants were considered symptomatic if a clinical diagnosis of 
CADASIL had been made by a physician before the study, based on a history 
of unexplained neurologic defi cits or cognitive decline and white matter 
abnormalities with or without lacunar lesions on MR imaging. Participants 
were considered asymptomatic if they had never consulted a physician 
with symptoms compatible with CADASIL. Migraine was not included in 
this defi nition. Control subjects consisted of asymptomatic family members 
without a NOTCH3 mutation. Disability at the time of the study was measured 
semiquantitatively with the Rankin scale. Sixty-three individuals participated 
in the study between August 1999 and July 2000. Only individuals cognitively 
capable of giving informed consent, and who did so, were included. The 
study was approved by the Medical Ethics Committee of the Leiden University 
Medical Centre.
MR imaging
MR examinations were performed on a 1.5 T MR system (Philips Medical 
Systems, Best, the Netherlands). T1-weighted spin echo (SE; slice thickness 6 
mm with a 0.6 mm interslice gap [6.0/0.6 mm], repetition time [TR] 600 ms, 
echo time [TE] 20 ms, matrix of 256 x 205), T2-weighted turbo SE (TSE; 3.0/0.0 
mm, TR/TE 3000/120 ms, 256 x 205), proton density-weighted (3.0/0.0 mm, 
3000/27 ms, 256 x 205), and fl uid-attenuated inversion recovery (FLAIR; 3.0/0.0 
mm, TR/TE 8000/100 ms, 256 x 192) images were obtained in the axial plane. To 
specifi cally detect cerebral microbleeds, T2*-weighted gradient echo planar 
imaging was performed (6.0/0.6 mm, TR/TE 2598/48 ms, 256 x 192), echo-
planar imaging factor, 25).
Microbleeds were defi ned as focal areas of signal loss on T2-weighted TSE 
images that increased in size on the T2*-weighted gradient echo planar images 
(“blooming effect”). In this way, microbleeds were differentiated from areas 
of signal loss based on vascular fl ow void. Areas of symmetric hypointensity 
in the basal ganglia likely to represent calcifi cation or nonhaemorrhagic iron 
deposits were disregarded. Finally, to differentiate microbleeds from other 
intra-axial lesions with a haemorrhagic component, only areas of signal loss 
that were not locally associated with other abnormalities were counted as 
microbleeds. The location, number, and size of microbleeds were recorded. 
White matter lesion load was graded according to the signal hyperintensity 
rating scale of Scheltens et al on T2-weighted TSE, proton density-weighted, and 
FLAIR images59. Lacunar lesions were defi ned as focal areas of hyperintense 
lesions on T2-weighted TSE images, with corresponding hypointense lesions on 
T1-weighted SE images. The signal intensity of these lesions corresponded with 
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that of the cerebrospinal fl uid . The number, location, and size of lacunar lesions 
were recorded. All MR images were reviewed by the same neuroradiologist, 
blinded to genetic and clinical data.
Mutation analysis
NOTCH3 mutation carriership was determined in all 63 individuals by direct 
sequencing analysis, according to previously described techniques22. Previously 
unreported NOTCH3 mutations were considered disease causative when 1) 
there was a change in the number of cysteine residues, typical for CADASIL 
mutations; 2) the mutations did not occur in 100 control chromosomes; and 3) 
the mutation clustered in affected family members.
To assess whether families with the same mutation had a common ancestor, 
haplotype analysis was performed with four polymorphic microsatellite 
markers (D19S929, D19S841, D19S1153, D19S917) located close to the NOTCH3 
gene.
Risk factors
Vascular comorbidity including hypertension, smoking, diabetes mellitus, 
history of myocardial infarction, and hypercholesterolemia was recorded 
in all subjects, with defi nitions similar to those in comparable studies, as 
follows55,58,60.
1. Hypertension: at least two blood pressure measurements of ≥150/95 mm Hg 
in the medical records of the preceding 5 years or two such measurements 
on the day of examination or current antihypertensive drug therapy;
2. Smoker: a person currently smoking at least one cigarette, cigar, or pipe 
per day for at least 1 year or who has done so in the past;
3. Diabetes mellitus: current use of oral antidiabetics or insulin;
4. Hypercholesterolemia: a cholesterol measurement of ≥7 mmol/L in the 
medical records of the preceding 5 years or current use of cholesterol-
lowering drugs; and
5. Myocardial infarction: a history of myocardial infarction in the medical 
records.
All individuals fi lled in a structured questionnaire concerning vascular risk 
factors. In addition, an extensive oral medical history, including medication 
use, was taken on the day of examination. All affected patients were 
accompanied by a clinically unaffected family member or spouse who, 
when necessary, supplied additional medical history. Questionnaires and 
history were validated with information from medical records supplied by the 
participants’ general practitioners and medical specialists.
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Statistical analysis
Statistical analysis was performed with SPSS-10 (SPSS, Inc., Chicago, IL). An 
exploratory analysis was performed to detect any association between the 
presence of cerebral microbleeds and demographic variables, vascular 
risk factors, concomitant MR abnormalities, and genotype. The association 
between microbleeds and the patient variables was studied in the setting of 
logistic regression. First, all univariate P values were computed, followed by 
the computation of P values after correction for age. A signifi cance threshold 
of P<0.05 was maintained.
Results
Table 1 gives an overview of the studied variables in carriers of NOTCH3 
mutations with and without microbleeds.
Characteristic Microbleeds,
n=10
No microbleeds, 
n=30
P (p*)
Age, y (range) 53.4 (43-58) 43.4 (21-59) ≤0.008
Male, n (%) 5 (50) 14 (47) ≤0.85
Hypertension , n (%) 0 3 (10) ≤0.3
Smoking, n (%) 6 (60) 19 (63) ≤0.85
Hypercholesterolemia, n (%) 3 (30) 12 (40) ≤0.6
Diabetes mellitus, n (%) 0 3 (10) ≤0.3
Myocardial infarction, n (%) 1 (10) 5 (17) ≤0.7
Antiplatelet use, n(%) 10 (100) 19 (63) ≤0.3 (0.025)
Antiplatelet use, 
mean y (range)
6.5 (1-10) 2.7 (0-12) ≤0.2 (0.003)
Mean antiplatelet dose, 
mg/d (range)
93.2 (38-240) 53.1 (0-300) ≤0.8 (0.07)
Dipyridamol, n (%) 4 (40) 4 (13) ≤0.5 (0.07)
Mean white matter 
lesion load (range)
53.8 (37-65) 41,4 (4-64) ≤0.9 (0.053)
Mean no. of lacunes (range) 34.1 (5-66) 16.9 (0-52) ≤0.3 (0.009)
Mean Rankin score (range) 2.8 (0-5) 1.5 (0-4) ≤0.6 (0.017)
Table 1 Characteristics of NOTCH3 mutation carriers with and without microbleeds
p* = P value before correction for age
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Mutation analysis and subjects
The 15 participating families had 11 different NOTCH3 mutations. Some families 
therefore shared the same genotype. Three mutations were not previously 
described in the literature (table 2). Per family, the number of participants 
varied from only the index patient to 10 members. The total number of 
participants was 63, but one participant had an incomplete MR study because 
of claustrophobia and was therefore excluded from the analysis. The mean 
± SD age of the remaining 62 participants was 43.8 ± 11.5 years (range 21 to 
67 years).
Forty participants had a mutation in the NOTCH3 gene, and 22 did not. Thirty-
two mutation carriers were symptomatic, with a wide range of severity from 
one TIA to multiple strokes and cognitive decline. Eight mutation carriers were 
asymptomatic. The mean age of the 40 mutation carriers was 45.9 ± 10.5 years 
(range 21 to 59 years) and of the 22 non mutation carriers 40.0 ± 12.7 years 
(range 22 to 67 years).
Microbleeds
Ten of the 40 participants (25%) with a NOTCH3 mutation had microbleeds. 
These 10 individuals were all clinically symptomatic. Thus, almost a third (31%) 
of the 32 symptomatic NOTCH3 mutation carriers had microbleeds. None 
of the eight asymptomatic mutation carriers and none of the 22 individuals 
without a NOTCH3 mutation had microbleeds.
Eighty-seven focal areas of signal loss were detected on T2*-weighted gradient 
echo images. Most of these were smaller than 5 mm in diameter (92%); the 
largest was 10 mm. These foci all resembled microbleeds in their homogeneous 
shape and distribution. Microbleeds were located predominantly in the 
thalamus (table 3; fi gure 1). Of the cerebral lobes, the occipital lobe had 
the most microbleeds (nine) compared with fi ve microbleeds in the temporal 
lobe, two in the parietal lobe, and one in the frontal lobe. Mutation carriers 
with microbleeds were signifi cantly older than mutation carriers without 
microbleeds, and microbleeds were present equally in men and women 
(table 1). All microbleeds occurred in patients with fi ve different mutations. Six 
of the mutations, therefore, were not associated with microbleeds. Of the 10 
patients with microbleeds, six had an Arg153Cys mutation. These six patients 
originated from two families: four individuals from one family and two from 
the other. Haplotype analysis showed that these families were unrelated. The 
Arg153Cys mutation is associated with microbleeds before (P=0.017) as well 
as after (P=0.037) correction for age.
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Concomitant cerebral MR abnormalities
The MR imaging results described here pertain only to the carriers of NOTCH3 
mutations (n=40). Mutation carriers all had white matter abnormalities on 
MR imaging. Individuals with microbleeds did not have a signifi cantly higher 
white matter lesion load than those without microbleeds but did have a 
signifi cantly higher lacunar lesion count (table 1). Those with microbleeds had 
more lacunae in the temporal lobe (P=0.025), occipital lobe (P=0.015), and 
thalamus (P<0.001). After correction for age, the difference in mean total 
lacunar lesion count disappeared.
Table 2 NOTCH3 mutations in study population
Genotype, exon Subjects with microbleeds 
n=10
Total mutated
n=40
Arg153Cys, 4 6 12
Arg141Cys, 4 1 9
Cys446Phe, *8 1 1
Arg207cys, 4 1 2
Arg544Cys, 11 1 1
Cys1015Arg, 19 0 3
Arg133Cys, 4 0 2
Arg182Cys, 4 0 4
Arg1076Cys,*20 0 3
Cys144Phe, 4 0 1
Cys162Trp, *4 0 2
* previously unreported NOTCH3 mutation
Table 3 Cerebral microbleed distribution in CADASIL
Cerebral structure No. of subjects with 
microbleeds in structure
Total no. of microbleeds, 
sum (range)
Subcortical white matter 5 23 (0-15)
Thalamus 8 53 (0-18)
Basal ganglia 2 2 (0-1)
Cerebellum 2 5 (0-4)
Brainstem 3 4 (0-2)
Cortex 0 0
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Vascular risk factors 
Vascular risk factors (hypertension, smoking, hypercholesterolemia, diabetes 
mellitus, and history of myocardial infarction) did not occur signifi cantly more 
in mutation carriers with microbleeds than in those without microbleeds 
(table 1). Hypertension and diabetes mellitus were not present in any of the 
individuals with microbleeds. Those with microbleeds had used antiplatelet 
drugs more (P=0.025) and longer (P=0.003) than those without microbleeds. 
These associations, however, disappeared after correction for age. One 
patient with microbleeds had a history of long-term anticoagulant use (>10 
years). A patient without microbleeds had started using anticoagulants just 
before the study, and one had a history of short-term anticoagulant use.
Rankin score
An association was found between Rankin score and microbleeds (P=0.017). 
After correction for age, however, this was no longer present.
 
a) b) 
Figure1 MR images at the level of the basal ganglia in a 55 year old patient with CADASIL. 
FLAIR image (a) shows periventricular and deep white matter hyperintensities and lacunes 
in the thalamus and basal ganglia (arrows). T2*-weighted gradient echo planar image (b) 
shows numerous circumscript hypodense lesions from previous microbleeds, located in the 
thalamus (arrowhead) as well as deep and subcortical white matter (white arrow).
Discussion
The main fi nding of the current study is that 31% of symptomatic NOTCH3 
mutation carriers had evidence of cerebral microbleeds on MR imaging. We 
postulate that the microbleeds are directly related to CADASIL arteriopathy, 
as known risk factors for cerebral bleeding, such as hypertension, were 
absent. CAA is a post-mortem diagnosis and therefore could not be excluded 
as a cause for the microbleeds. However, it is unlikely to have played a role, 
owing to the relatively young age of our study population and the mainly 
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thalamic location of the microbleeds, both of which are atypical for CAA61. 
Hereby, the borders of CADASIL disease expression are expanded beyond 
that of a purely ischemic cerebral disease, to include cerebral bleeding. A 
relevant clinical implication is that patients with CADASIL may be at increased 
risk of pICH, which has been shown to be associated with the presence of 
microbleeds54,56,57,62.
In this CADASIL population, the Arg153Cys mutation is an independent risk 
factor for microbleeds. Although confi rmation of this fi nding is warranted 
because of the small sample size and the exploratory nature of this study, it 
supports the possibility that various NOTCH3 mutations may lead to differences 
in severity or pattern of disease expression, as has been suggested by other 
authors63,64.
Microbleeds were found to be age related, and their presence may thus 
refl ect disease progression in CADASIL. This is also suggested by the fact that 
microbleeds occurred in areas with a large number of lacunae. Possibly, the 
more damaged the intracerebral vessels become (refl ected in increased 
number of lacunae), the more bleed-prone they tend to get. However, the 
total number of lacunae and other MR and clinical data refl ecting disease 
progression, such as the Rankin scale and white matter lesion load, were 
higher in patients with microbleeds, but not within the range of signifi cance 
after correction for age (table 1).
ICH has so far rarely been reported in patients with CADASIL. Several 
explanations could account for this. First, when pICH occurs, the underlying 
CADASIL may be obscured and thus remain undiagnosed, especially because 
pICH is classically considered not to form part of the CADASIL disease spectrum. 
A second explanation could be that true pICH in CADASIL is provoked only 
when additional risk factors are present. Interestingly, of the two CADASIL 
patients with pICH reported in the literature, one died as a consequence of 
this at age 30, 6 months after starting anticoagulant therapy1,7. In our study, 
previous anticoagulant use was recorded in only one patient with microbleeds. 
Therefore, whether anticoagulants play a role in CADASIL ICH, as has also 
been found in other small-vessel disease, remains to be determined65. We did 
fi nd that patients with microbleeds used antiplatelet drugs more and longer 
than those without microbleeds. However, the signifi cance of this fi nding was 
lost after correction for age, implying that antiplatelet drug therapy probably 
does not play a role in increased risk for cerebral bleeding in CADASIL. To 
avoid missing the diagnosis and to further delineate the disease spectrum, 
CADASIL should be considered in the diagnostic workup of (normotensive) 
patients presenting with pICH and concomitant white matter abnormalities 
on MR imaging. 
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Abstract
Purpose was to assess the prevalence and distribution of subcortical 
lacunar lesions (SLLs) in patients with cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy 
(CADASIL), to determine whether SLLs are an abnormal fi nding by 
studying their prevalence in healthy subjects, and to assess whether 
SLLs occur in other conditions associated with small vessel disease 
and white matter areas of high signal intensity (WMHs).
The presence of SLLs, their location, and their relation to other 
abnormalities were assessed on magnetic resonance (MR) images 
(T1-weighted, T2-weighted, and fl uid-attenuated inversion-recovery) 
obtained in 34 CADASIL patients and 20 healthy family members. 
Three additional control groups of healthy volunteers, elderly patients 
with vascular risk factors, and patients with another hereditary small 
vessel disease were also screened for the presence and location of 
SLLs. Sensitivity and specifi city of the presence of SLLs for the diagnosis 
of CADASIL were assessed.
SLLs were found in 20 (59%) of CADASIL patients. Incidence of SLLs 
increased with age (20%, <30 years; 50%, 30–50 years; 80%, >50 years). 
SLLs invariably occurred in the anterior temporal lobes and in areas 
where diffuse WMHs expanded into arcuate fi bers. From the anterior 
temporal lobe, the lesions could extend dorsally into the temporal 
lobes and rostrally into the frontal lobes. Lesions were not found in 
the parietal and occipital lobes. None of the control subjects had 
SLLs. Specifi city and sensitivity of SLLs for CADASIL were 100% and 59%, 
respectively.
SLLs are an abnormal fi nding at MR imaging that frequently occur in 
CADASIL patients.
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Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is a hereditary small artery vasculopathy 
caused by mutations in the NOTCH3 gene on chromosome 1919,45,66. The disease 
is characterized clinically by transient ischemic attacks, strokes, progressive 
subcortical dementia, migraine with aura, and mood disturbances8,10,11. 
Pathologic examination of the brain demonstrates characteristic depositions of 
granular osmiophilic material within the media of the small and medium-sized 
leptomeningeal and long perforating arteries of the brain. The vasculopathy 
results in destruction of smooth muscle cells and fi brous thickening of the 
arterial wall7. Magnetic resonance (MR) imaging in patients with CADASIL 
typically reveals diffuse white matter areas with high signal intensity (WMHs) 
and lacunar infarcts in the centrum semiovale, thalamus, basal ganglia, 
and pons39-41. In symptomatic patients, MR images of the brain are always 
abnormal, but signal intensity abnormalities have also been detected in 
asymptomatic individuals who have the NOTCH3 mutation45.
The diagnosis of CADASIL is confi rmed by the demonstration of mutations in 
the NOTCH3 gene; this confi rmation process, however, is laborious because 
the NOTCH3 gene is large, comprising 33 exons (i.e., distinct parts of genes 
which often encode discrete structural and functional units of proteins). 
Although 65% of known mutations occur in exons 3 and 4, the remaining exons 
must be screened, as well, in many cases. MR imaging plays an important 
role in the diagnostic work-up to increase the chance that CADASIL will be 
detected with genetic screening. It has recently been demonstrated that 
CADASIL can be differentiated from Binswanger’s disease at MR imaging, 
but differentiation of CADASIL from other diseases that can be associated 
with white matter abnormalities is unclear67. Therefore, the discovery of more 
specifi c neuroimaging features of CADASIL might help increase the chance 
of identifying CADASIL patients.
Recently, we reviewed brain MR imaging studies of members of families with 
CADASIL as part of a study on the clinical, radiologic, and genetic aspects 
of CADASIL in the Netherlands. During this study, we observed a pattern of 
subcortical lacunar lesions (SLLs) in patients with CADASIL that, to the best of 
our knowledge, has not been previously described. The aim of the present 
study was threefold: to assess the prevalence and distribution of SLLs in CADASIL 
patients, to determine whether SLLs are an abnormal fi nding by studying their 
prevalence in a control series of healthy subjects from the general population, 
and to assess whether SLLs occur in other conditions that are associated with 
small vessel disease and WMHs.
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Materials and methods
Members of 15 unrelated Dutch families with CADASIL were asked to participate 
in a study on the clinical, radiologic, and genetic aspects of CADASIL. In each 
family, the index patient had a proven pathogenic NOTCH3 mutation. Patients 
were referred from various medical centres to our institution, which serves as a 
CADASIL referral centre. Patients were referred because they were suspected 
of having CADASIL on the basis of clinical signs and symptoms, a family history 
consistent with autosomal dominant inherited disease, or suggestive changes 
at MR imaging such as WMHs and lacunar infarcts. The presence of SLLs was 
never the reason for referral. At our institution, the diagnosis of CADASIL was 
confi rmed with direct sequencing analysis of the NOTCH3 gene according 
to previously described techniques22. Thirty-four patients formed the group in 
our study.
The following four control groups were used: 
1. Members of CADASIL families without the NOTCH3 mutation. 
2. A group of 75 adult subjects (<65 years of age) who were randomly 
recruited from the general population, did not have abnormalities at 
standard neurologic examination, and had no history of cardiovascular 
events.
These two groups served to assess whether SLLs occur in evidently healthy 
individuals.
To assess whether SLLs occur in patients with other conditions that are 
associated with small vessel disease and WMHs, we studied two additional 
control groups:
3. A group of 16 age-matched patients with DNA-proven hereditary 
cerebral haemorrhage with amyloidosis–Dutch type (HCHWA-D). HCHWA-D 
is an autosomal dominant small vessel disease of the brain caused by ß-
amyloid depositions in cerebral arterioles and leptomeningeal arteries that 
is associated with extensive supratentorial WMHs68-70.
4. A group of 75 elderly subjects (>70 years) from the general population with 
an increased risk of having cerebral WMHs because they had cardiovascular 
disease or at least one major vascular risk factor (hypertension, cigarette 
smoking, or diabetes mellitus; for criteria see reference 16). These subjects 
were randomly selected from a larger study group that had participated in 
a randomized controlled trial investigating the effect of cholesterol-lowering 
treatment with pravastatin on cardiovascular disease and stroke. All subjects 
were imaged at baseline71.
The patients in all control groups underwent the same MR imaging protocol as 
the patients with CADASIL. Only cognitively capable subjects were included 
in this study to ensure informed consent. The medical ethics committee of 
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our institution approved the protocol of our entire study. Informed consent 
was obtained from all subjects in each of the four control groups and from all 
subjects in the CADASIL group.
All MR imaging examinations were performed with a 1.5-T MR system (Philips 
Medical Systems, Best, the Netherlands) between August 1999 and June 
2001. Conventional T1-weighted spin-echo images (section thickness, 6 mm; 
intersection gap, 0.6 mm; repetition time msec/echo time msec, 600/20; 
matrix, 256 x 205; fi eld of view, 220 x 165 mm), dual T2-weighted fast spin-echo 
images (section thickness, 3 mm; no intersection gap; 3000/27, 120; matrix, 256 
x 205; fi eld of view, 220 x 220 mm), and fast fl uid-attenuated inversion-recovery 
(FLAIR) images (section thickness, 3 mm; no intersection gap; repetition time 
msec/echo time msec/inversion time msec, 8000/100/2000; matrix, 256 x 192; 
fi eld of view, 220 x 176 mm) were obtained. To detect haemosiderin deposits, 
we performed a T2*-weighted gradient-echo pulse (echo-planar imaging 
[EPI]) sequence (section thickness, 6 mm; intersection gap, 0.6 mm; 2598/48; 
matrix, 256 x 192; fi eld of view, 220 x 198 mm; EPI, 25). All sequences were 
performed in the axial plane parallel to the inferior border of the genu and 
splenium of the corpus callosum.
SLLs were defi ned as linearly arranged groups of rounded, circumscribed 
lesions just below the cortex at the junction of the grey and white matter with a 
signal intensity that was identical to that of cerebrospinal fl uid (CSF) on images 
obtained with all pulse sequences. On each section of the brain, the following 
aspects of SLLs were assessed: anatomic location, distribution, bilaterality, size, 
and relation to other abnormalities such as WMHs and haemosiderin deposits. 
With the validated visual rating score of Scheltens et al, deep white matter 
lesions were rated on the basis of fi lm hard copies of FLAIR MR images59. A 
Scheltens score of deep WMHs of 1 or more was considered to indicate 
presence of WMHs, while a score of 0 implied absence of deep WMHs. When 
SLLs were visible, the presence of haemosiderin deposits in the vicinity of the 
SLLs was recorded on the basis of T2*-weighted gradient-echo MR images. In 
addition, prevalence of SLLs in the groups of CADASIL patients and control 
subjects was assessed. Finally, in CADASIL patients, prevalence of SLLs was 
established in male and female patients separately, and the relationship 
between SLLs and age was established. All MR images were reviewed by 
the same neuroradiologist (MAvB) who was blinded to clinical and genetic 
data.
During this study, we reviewed histologic information about any subject 
participating in the study in whom this information might be available. In 
one patient who died and in whom we found SLLs before death, we had 
the opportunity to investigate formalin-fi xed tissue of the anterior temporal 
lobe (tissue was investigated with permission of the family and was kindly 
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supplied by Frits F.J.M. Sutorius, MD, Stichting Laboratorium Pathologie Oost 
Nederland, Enschede, the Netherlands). Tissue was embedded in paraffi n, 
and haematoxylin-eosin and Klüver-Barrera stains were used.
Descriptive statistics were calculated for differences in age and sex and for 
the presence of SLLs in various areas of the brain. The sensitivity and specifi city 
of the presence of SLLs for the diagnosis of CADASIL were calculated by 
comparing data from CADASIL patients with data from the elderly subjects 
and from the HCHWA-D patients. Comparisons after grouping subjects by age 
(i.e., <30 years, 30–50 years, and >50 years) were assessed with the Fisher exact 
test. Values of P<0.05 were considered to represent a statistically signifi cant 
difference. The statistical analysis was performed with SPSS-10 software (SPSS, 
Chicago, Ill).
Results
The total number of participants from families with CADASIL was 54. Thirty-four 
participants had a mutation in the NOTCH3 gene and 20 did not (for group 
characteristics, see table 1). In the majority of NOTCH3 mutation carriers, the 
mutation was located in exon 4; in the remaining patients, it was located in 
exon 8, 19, or 20. Twenty-six mutation carriers were symptomatic; eight were 
asymptomatic. The group of mutation carriers included 17 women and 17 
men, with a mean age of 45 years ± 12 (SD) and 46 years ± 11, respectively. 
In all CADASIL patients, deep WMHs were present. Eight (40%) of the CADASIL 
family members without mutations, 44 (59%) of the normal adults, 11 (69%) of 
the HCHWA-D patients, and 64 (85%) of the elderly patients with vascular risk 
factors had deep WMHs.
Table 1 Characteristics of study groups
Study group No. of 
subjects
Age (y) Sex
No. of 
SLLs Mean ± SD Range Men women
CADASIL patients 34 46 ± 11 21-60 17 17 20
CADASIL family members 
without mutation
20 40 ± 13 22-67 8 12 0
Healthy control subjects 75 48 ± 8 34-62 24 51 0
Elderly with vascular risk 
factors
75 78 ± 3 72-85 56 19 0
HCHWA-D patients 16 48 ± 9 34-63 10 6 0
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Figure 1 Axial MR images in patient with CADASIL at the level of the pons. Hyperintense 
confl uent white matter lesions in the temporal lobe are visible on (a) a FLAIR image and a 
(b) T2-weighted image. On the FLAIR image, the SLLs (arrowheads) are clearly visible on the 
T2-weighted image they hardly be discriminated from the adjacent WMHs.
 
a) b) 
Because of the high contrast between SLLs and WMHs on FLAIR MR images, 
SLLs were detected only on these images. Therefore, the results given next 
are based on the visibility of SLLs on FLAIR MR images. SLLs were found in 20 
of 34 CADASIL patients (59%; mean age, 49 years ± 8) (table 1). The signal 
intensity of SLLs was equivalent to that of CSF on images obtained with all 
pulse sequences. The low contrast between these lesions and the abutting 
confl uent areas with low signal intensity on T1-weighted images and high 
signal intensity on T2-weighted images lessened the visibility of SLLs with these 
sequences (fi gure 1). None of the four control groups had SLLs (table 1). 
Specifi city and sensitivity of the presence of SLLs in CADASIL were 100% (95% 
CI: 98, 100) and 59% (95% CI: 41, 75), respectively (table 2). SLLs were found 
in one (20%) of fi ve patients less than 30 years of age, in seven (50%) of 14 
patients 30–50 years of age, and in 12 (80%) of 15 patients more than 50 years 
of age. The difference in prevalence of SLLs between these three age groups 
was signifi cant (P<0.05). SLLs were more prevalent in male CADASIL patients: 
Eight female (47% of all women) versus 12 male (71% of all men) patients were 
affected, but the difference was not signifi cant (P>0.05). When SLLs were 
present, they were numerous, their size varied between 1 and 2 mm, and they 
occurred in all cases in the temporopolar part of the brain (defi ned as the 
part anterior to the temporal horns67). In four patients, the lesions expanded 
from this anterior location posteriorly and affected the entire temporal lobe 
(fi gures 2a, 2b). In fi ve patients (25%), SLLs were also located in the operculum 
of the frontal lobe (fi gure 2c). In one patient with extensive white matter 
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c) d) 
Figure 2 Axial FLAIR MR images in four CADASIL patients at the level of (a) the pons, (b) the 
operculum of the temporal lobe, (c) the basal ganglia, and (d) the high convexity. Images 
show bilateral SLLs affecting a) the anterior part and (b) the operculum of the temporal lobe 
(arrowheads) at the junction of grey and white matter. The lesions are abutting WMHs (arrow 
in a). From this location, lesions could expand to (c) the subinsular region and operculum 
of the frontal lobe (arrowheads). (d) In one patient with extensive white matter lesions, 
subcortical lacunar lesions were visible throughout the whole frontal lobe (arrows). 
lesions, SLLs were visible throughout the whole temporal and frontal lobes 
(fi gure 2d). SLLs were never observed in the parietal and occipital lobes or 
infratentorially. The lesions had a symmetric distribution in 85% of patients; in 
15% of patients, SLLs occurred unilaterally. SLLs invariably abutted white matter 
areas, with confl uent areas of high signal intensity on FLAIR MR images. They 
were never found in juxtaposition to white matter with a normal appearance 
on images obtained with this sequence. The surface of the SLLs that abutted 
the cortical ribbon did not show signal intensity abnormalities. No evidence of 
haemosiderin deposits was found in the vicinity of the lesions.
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Histologic examination of the tissue sections of the anterior temporal lobe 
from one patient revealed vascular changes characteristic of CADASIL7. 
Furthermore, when slides were viewed macroscopically, they showed in 
several areas a typical periodicity of lacunae perpendicular to the border of 
the grey and white matter. This phenomenon was caused microscopically by 
a clear zone around perforating vessels (fi gure 3b). These vessels occasionally 
showed a thickened wall with granular material but often lacked obvious 
changes. The clear zone consisted of a distended perivascular space, 
which often contained some haemosiderin, and spongiosis (oedema) of 
the adjacent parenchyma (fi gure 3c). A row of several of these periodically 
arranged lacunae represent the substrate for the linear lesions observed at 
MR imaging (fi gure 3a).
Table 2 Visibility of SLLs on FLAIR MR Images in the CADASIL group and in two other groups 
with conditions associated with small vessel disease and WMHs (elderly patients with vascular 
risk factors and patients with HCHWA-D)
SLLs status CADASIL patients Elderly and HCHWA-D patients 
(n = 91)
Present 20 0
Absent 14 91
Total 34 91
Note: The fi nding of SLLs on FLAIR MR Images has a sensitivity of 59% and a specifi city of 
100% for the diagnosis of CADASIL.
Discussion
In this article, we describe a type of lacunar lesion that, to our knowledge, has 
not been previously described in the neuroimaging literature in either patients 
with CADASIL or patients with other disorders. Microscopic examination 
reveals that the lacunae are caused by a distention of the perivascular space 
of perforating arteries at the level of the junction of grey and white matter 
and by spongiosis in the surrounding parenchyma. The observed widened 
perivascular space, which is known to contain CSF, provides an explanation 
for the observation in our study that the signal intensity of SLLs at MR imaging 
was equivalent to that of CSF. Furthermore, the presence of spongiosis in the 
surrounding parenchyma may explain the confl uent aspect of SLLs that is 
frequently found at MR imaging. The abnormalities we found microscopically 
have a strong resemblance to the laminar lacunar lesions between the 
cortical ribbon and the subcortical white matter that have been described 
by Ruchoux et al in a post-mortem study of a patient with CADASIL34. The 
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presence of spongiosis and haemosiderin in the surrounding parenchyma 
suggests local damage to the blood-brain barrier at the junction of grey and 
white matter in perforating arteries.
 
a) 
c) 
b) 
Figure 3 Axial FLAIR MR image (a) in a patient with CADASIL in whom we obtained formalin-
fi xed tissue of the anterior temporal lobe after death. Subcortical lacunar lesions are present 
in the temporal lobe (arrowhead). Photomicrograph (b) shows a row of perforating vessels 
at the border of grey matter (top of image) and white matter with an obvious clear zone 
(arrowheads). (Klüver-Barrera stain; original magnifi cation, x20.) Photomicrograph (c) shows 
detail of two vessels. The lower part of the vessel on the left shows characteristic thickening 
of the arterial wall; both vessels have a distended perivascular space (arrows) and 
spongiosis of the adjacent parenchyma (arrowhead). (Haematoxylin-eosin stain; original 
magnifi cation, x100.
Despite the histologic similarity of SLLs to dilated perivascular or Virchow-Robin 
spaces, it is possible to distinguish SLLs from otherwise widened Virchow-Robin 
spaces on MR images based on their location. At MR imaging, widened 
Virchow-Robin spaces are often seen in healthy individuals in the deep white 
matter of the high convexity, at the base of the brain adjacent to the anterior 
or posterior surface of the lateral portion of the anterior commissure, in the 
midbrain, and in the subinsular white matter72. SLLs cannot be confused with 
Virchow-Robin spaces in the white matter of the high convexity, at the base of 
the brain, and in the midbrain because (a) SLLs occur only at the subcortical 
junction of the grey and white matter and (b) the sites of predilection of SLLs 
are the anterior, temporal, and frontal lobes, where Virchow-Robin spaces are 
not usually found in healthy individuals. SLLs with a subinsular location could 
be confused with Virchow-Robin spaces because of their location. However, 
unlike Virchow-Robin spaces, SLLs appear only in the presence of WMHs, are 
always accompanied by SLLs in the anterior temporal lobe, and do not have 
the featherlike appearance that is characteristic of Virchow-Robin spaces in 
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this location73. In addition to being confused with Virchow-Robin spaces, SLLs 
can also be confused with normal variations in the temporal lobe. Hippocampal 
sulcus remnants are apparent at MR imaging as small circumscribed areas with 
a signal intensity similar to that of CSF in the hippocampus74. These structures 
can be differentiated from SLLs by their location because hippocampal sulcus 
remnants occur within the hippocampus and are surrounded by hippocampal 
grey matter, whereas SLLs are seen only at the cortical junction of grey and 
white matter. Furthermore, contrary to hippocampal sulcus remnants, SLLs will 
never appear only in this region; they are always accompanied by SLLs in the 
anterior part of the temporal lobe.
In this study, we observed SLLs in the temporal lobes and to a lesser extent 
in the frontal lobes. Within the temporal lobes, the anterior (temporopolar) 
part was a site of predilection for SLLs; this area was invariably affected in 
patients with SLLs. This distribution pattern of SLLs closely resembles the 
pattern of WMHs in CADASIL patients that has recently been described. 
Both Auer et al and O’Sullivan et al demonstrated that temporal pole WMHs 
are a characteristic fi nding of CADASIL, which enables the differentiation of 
CADASIL from Binswanger‘s disease43,67. In addition, Auer et al demonstrated 
that expansion of WMHs into the arcuate fi bers is typical of CADASIL; this 
fi nding further helps in differentiating CADASIL from Binswanger’s disease67. 
In addition to this similarity in distribution of SLLs and WMHs, in our study, SLLs 
were always observed to be abutting WMHs that had expanded into the 
subcortical arcuate fi bers. The similarity in distribution of SLLs and WMHs and 
their invariable side-by-side occurrence suggests that they have the same 
pathogenesis. Both phenomena probably result from local degeneration of 
the perforating arteries at the level of the cortical junction of grey and white 
matter. The observation that SLLs were never found without WMHs expanding 
into arcuate fi bers, whereas such WMHs lesions were found without SLLs, 
suggests that WMHs precede the occurrence of SLLs and that SLLs are a 
manifestation of more advanced disease than are WMHs.
Although SLLs were found in the majority of patients with CADASIL in our 
study, to our knowledge, the presence of SLLs has not been reported in the 
numerous previously published articles on neuroimaging fi ndings in patients 
with CADASIL. This discrepancy between our and other imaging studies might 
be explained by our use of FLAIR MR images with thin sections (3 mm). In 
most previous MR imaging studies of CADASIL, only T1- and T2-weighted MR 
images were used for detecting brain lesions39-41. On T1- and T2-weighted 
images, SLLs are hard to detect because both SLLs and WMHs have low signal 
intensities on T1-weighted images and high signal intensities on T2-weighted 
images. The similar signal intensities and the existence of SLLs and WMHs in 
close proximity make it hard to detect the subtle SLLs at the border of the 
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larger and more obvious confl uencing WMHs. However, on FLAIR images, a 
high contrast is generated between SLLs and WMHs. On FLAIR images, the 
signal intensity of CSF is selectively suppressed, rendering CSF and CSF-fi lled 
structures black, whereas the high signal intensity of most pathologic changes 
of brain parenchyma is maintained. Because of this high contrast, the CSF-
fi lled SLLs are clearly visible on FLAIR MR images as black lesions between the 
grey cortex and the WMHs. Because SLLs are small, they are more visible when 
thin sections are used.
In conclusion, SLLs are a previously unreported imaging fi nding in patients with 
CADASIL. In this study, SLLs were found in 59% of patients with CADASIL; this 
suggests that SLLs are characteristic of the disease. SLLs were not found in 
healthy control subjects, which suggests that SLLs are not a normal condition 
like the physiologic Virchow-Robin spaces that are often detected at MR 
imaging in healthy individuals. SLLs were not found in two other populations 
with a high prevalence of WMHs induced by small vessel disease. This suggests 
that SLLs might be specifi c for CADASIL, and that detection of their presence 
may help to narrow the differential diagnosis and even establish the diagnosis 
in patients with WMHs. Further studies of the occurrence of SLLs in other 
cerebral diseases are needed to assess the specifi city of SLLs for CADASIL. 
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Abstract
Purpose was to depict various brain lesions that have been described 
in patients who have cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy (CADASIL) with 
prospective standardized magnetic resonance (MR) imaging in 
patients of different age groups.
Forty patients with CADASIL in different age groups (20–30 years, n=5; 
31–40 years, n=4; 41–50 years, n=16; 51–60 years, n=15) underwent axial 
MR imaging with T1-weighted dual fast spin-echo, fl uid-attenuated 
inversion-recovery, and T2*-weighted gradient-echo sequences. 
Images were analyzed by one neuroradiologist for the presence of 
areas of hyperintensity, lacunar infarcts, microbleeds, and subcortical 
lacunar lesions (SLLs) in different anatomic locations. Descriptive 
statistics were obtained for the presence of MR imaging abnormalities 
in various brain areas and for distribution according to age.
The mean age of the 40 mutation carriers (21 women, 19 men) was 
45 years ± 10 (SD). In patients with CADASIL who were 20–30 years old, 
characteristic hyperintense lesions in the anterior temporal lobe (100% 
[fi ve of fi ve]) and SLLs (20% [one of fi ve]) were the only abnormalities 
seen on MR images. In patients who were 30–40 years old, lacunar 
infarcts were found in 75% (three of four) of cases. More areas of 
hyperintensity were noted, and they frequently involved the external 
capsule, basal ganglia, and brainstem. In patients 41–50 years old, 
microbleeds were observed in 19% (three of 16). In patients older than 
50 years, areas of hyperintensity (100% [15 of 15]), SLLs (73% [11 of 15]), 
lacunar infarcts (93% [14 of 15]), and microbleeds (47% [seven of 15]) 
were frequently observed.
The four types of brain lesions that are observed in patients with 
CADASIL were seen in patients of different age groups.
41
CADASIL: MR imaging fi ndings at different ages, 3rd-6th decade
Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is an inherited systemic disease of the 
small artery caused by mutations in the NOTCH3 gene on chromosome 1919. 
Histopathological studies of the small and medium-sized leptomeningeal 
arteries and the long perforating arteries of the brain revealed luminal 
narrowing or even obliteration caused by deposition of electron-dense 
granular material close to the membrane of the vascular smooth muscle 
cells, as well as loss of vascular smooth muscle cells7. Clinical manifestations 
of the disease include ischemic stroke, dementia, migraine with aura, and 
mood disturbances75. The fi rst clinical manifestations of the disease often start 
in patients during the 3rd decade, and death often occurs in patients during 
the 6th decade75. Main magnetic resonance (MR) imaging fi ndings in patients 
with CADASIL are diffuse areas of hyperintensity of white matter that occur 
predominantly in the subcortical areas and lacunar infarcts that are present 
in the semiovale centre, the thalamus, the basal ganglia, and the pons39-41. 
Recent MR imaging study fi ndings demonstrated microbleeds and subcortical 
lacunar lesions (SLLs) as additional radiologic features of CADASIL76-78.
The defi nite diagnosis of CADASIL is established with detection of NOTCH3 
mutations, and detection of these mutations is a laborious process that is 
performed at a limited number of specialized centres. Presently, NOTCH3 
mutation analysis is considered only in patients who have unexplained 
neurologic symptoms, such as ischemic episodes, cognitive defi cits, and a 
positive family history of these symptoms, and who have suggestive MR imaging 
abnormalities. The radiologic fi ndings of patients with advanced stages of the 
disease are well documented. On the basis of these descriptions, radiologists 
can adequately help in the identifi cation of patients with an indication for 
further molecular or pathologic testing for CADASIL39-43,67. However, the 
radiologic appearances during earlier stages of the disease have not been 
described in detail, and this lack of information may lead to inadequate 
guidance of patients through the diagnostic work-up.
To our knowledge, fi ndings of the only published study about the development 
of cerebral changes over time in patients with CADASIL were reported by 
Chabriat et al39. In that study, the development of areas of hyperintensity 
and of lacunar infarcts was studied in the periventricular and subcortical 
white matter, the basal ganglia, and the infratentorial areas. However, after 
publication of that study, other radiologic hallmarks of CADASIL, such as SLLs, 
microbleeds, and areas of hyperintensity in the anterior temporal lobe and in 
the external capsule, were detected667,76-78. The temporal evolution of these 
more recently described radiologic phenomena of CADASIL remains to be 
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elucidated. Thus, the purpose of our study was to depict various brain lesions 
that have been described in patients who have CADASIL with prospective 
performance of standardized MR imaging in patients of different age 
groups.
Materials and methods
Subjects
Members of 15 unrelated Dutch families who had CADASIL were asked to 
participate in a study about the clinical, radiologic, and genetic aspects 
of CADASIL in patients from the Netherlands. In each family, at least one 
member had a confi rmed NOTCH3 mutation. These patients were referred 
to Leiden University Medical Centre from various medical centres; this 
institution serves as a national CADASIL referral centre. The total number of 
participants was 63 and included symptomatic, as well as asymptomatic, 
family members. Participants were considered symptomatic when they had 
a history of neurologic defi cits or cognitive decline. The diagnosis of CADASIL 
was confi rmed after the MR imaging examination with identifi cation of 
pathogenic mutations of the NOTCH3 gene, as previously described22.
The families included in this study were all of the families seen between August 
1999 and July 2000. To ensure informed consent, only cognitively capable 
subjects were included in this study. The institutional medical ethics committee 
approved the study protocol. Since one individual of the 63 participants did 
not consent to undergo MR imaging, the fi nal number of subjects was 62; 40 of 
these subjects had a mutation in the NOTCH3 gene and 22 did not.
MR imaging
All MR imaging examinations were performed with a 1.5-T MR system (Philips 
Medical systems, Best, the Netherlands). Participants underwent MR imaging 
with a standardized protocol that included the following: conventional T1-
weighted spin-echo (repetition time msec/echo time msec, 600/20; section 
thickness, 6.0 mm; intersection gap, 0.6 mm; matrix, 256 x 205; fi eld of view, 220 
x 165 mm), dual T2-weighted fast spin-echo (3000/27, 120; section thickness, 
3.0 mm; intersection gap, 0 mm; matrix, 256 x 205; fi eld of view, 220 x 220 
mm), and fast fl uid-attenuated inversion-recovery (FLAIR) (repetition time 
msec/echo time msec/inversion time msec, 8000/100/2000; section thickness, 
3.0 mm; intersection gap, 0 mm; matrix, 256 x 192; fi eld of view, 220 x 176 
mm) sequences. In addition, a T2*-weighted gradient echo planar (2598/48; 
section thickness, 6.0 mm; intersection gap, 0.6 mm; matrix, 256 x 192; fi eld 
of view, 220 x 198 mm; echo-planar imaging factor, 25) sequence was 
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performed to detect haemosiderin deposits. All images were obtained in the 
axial plane parallel to the inferior border of the genu and splenium of the 
corpus callosum.
Areas of hyperintensity were defi ned as areas of brain parenchyma with 
increased signal intensity on intermediate, T2-weighted, and FLAIR MR images, 
and they were rated from hard copies of axial dual T2-weighted fast spin-
echo MR images with the semiquantitative visual scoring system described by 
Scheltens et al59. In this scale, the brain is anatomically divided into deep white 
matter, basal ganglia, and infratentorial regions. For each region, a score of 
0–6 is assigned according to the following scale: score 0, absent; score 1, up 
to fi ve areas of white matter hyperintensity of less than 3 mm in diameter; 
score 2, six or more areas of white matter hyperintensity of less than 3 mm in 
diameter; score 3, as many as fi ve areas of white matter hyperintensity of 4–10 
mm in diameter; score 4, six or more areas of white matter hyperintensity of 4–
10 mm in diameter; score 5, one or more areas of white matter hyperintensity 
of more than 10 mm in diameter; and score 6, confl uent areas of white matter 
hyperintensity. In addition, scores were assigned to the frontal and occipital 
periventricular “caps” and periventricular “bands” as follows: score 0, absent; 
score 1, as much as 5 mm in diameter; and score 2, more than 5 mm in 
diameter. Because the Scheltens scoring system does not fully refl ect the 
characteristic lesion distribution in patients who have CADASIL, three anatomic 
locations were added to the Scheltens score: external and internal capsule 
and the temporal region. The external and internal capsules were assigned 
separate scores for the presence of areas of subcortical hyperintensity, and 
the temporal region was assigned a separate score for the presence of areas 
of periventricular hyperintensity. In our experience, areas of hyperintensity in 
young patients who have CADASIL often are located in the anterior temporal 
lobe; for this reason, we assigned separate scores for the presence of areas 
of hyperintensity in the anterior temporal lobe and the posterior temporal 
lobe. We defi ned the border between the anterior temporal lobe and the 
posterior temporal lobe as the posterior margin of the amygdala43. To obtain 
an overall supratentorial lesion load score, the periventricular score was 
added to the Scheltens subcortical score. To calculate the prevalence of 
areas of hyperintensity, a Scheltens score of 1 or higher was considered to be 
positive for areas of hyperintensity, and a score of 0 implied absence of areas 
of hyperintensity.
Lacunar infarcts were defi ned as parenchymal defects that did not extend to 
the cortical grey matter, with a signal intensity similar to that of cerebrospinal 
fl uid with all pulse sequences, irrespective of size. There are three locations 
where lacunar infarcts can be diffi cult to distinguish from normal Virchow-
Robin spaces: the basal ganglia, the subinsular region, and the semiovale 
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centre. To differentiate a lacunar infarct from a Virchow-Robin space, 
we excluded lesions in the following areas because they were most likely 
to represent a Virchow-Robin space: (a) basal ganglia: lesions that were 
isointense to cerebrospinal fl uid with all pulse sequences and were located 
in the lower one-third of the corpus striatum79,80; (b) subinsular region: areas 
with a featherlike confi guration that were isointense to cerebrospinal fl uid on 
T1- and T2-weighted MR images but did not have high signal intensity on FLAIR 
images73; (c) semiovale centre: all lesions with a transverse diameter of 2 mm 
or smaller or with a tubular appearance following the course of perforating 
arteries81.
Microbleeds were defi ned as focal areas of signal intensity loss on T2-
weighted fast spin-echo MR images that increased in size on the T2*-weighted 
gradient-echo images (“blooming effect”)76. In this way, microbleeds were 
differentiated from areas of signal loss that were based on vascular fl ow voids. 
Areas of symmetric hypointensity of the globus pallidus that were likely to 
represent calcifi cation or nonhemorrhagic iron deposits were excluded.
SLLs were defi ned as linearly arranged groups of rounded circumscribed lesions 
that were just below the cortex at the grey matter–white matter junction and 
had a signal intensity that was identical to that of cerebrospinal fl uid with all 
pulse sequences78.
One experienced neuroradiologist (MAvB) who was blinded to the diagnosis 
of CADASIL assessed the presence of areas of hyperintensity, lacunar 
infarcts, microbleeds, and SLLs in all 62 participants. For lacunar infarcts and 
microbleeds, size and number were assessed in the following brain areas: 
supratentorial region (frontal, temporal, occipital, and parietal lobes and 
internal and external capsules), infratentorial region (cerebellum, pons, 
medulla oblongata, and mesencephalon), thalamus, and basal ganglia 
(globus pallidus, caudate nucleus, and putamen). The presence of SLLs was 
assessed in each patient who had CADASIL.
Statistical analysis
Descriptive statistics were obtained in regard to the presence of MR imaging 
abnormalities in various areas of the brain according to age (percentage 
of patients affected per anatomic structure per decade). Differences in 
areas of hyperintensity, lacunar infarcts, and microbleeds between male 
and female patients who had CADASIL were investigated with the Student 
t-test for unpaired data. Differences in SLLs were tested by using the Χ2 test. 
A difference with P<0.05 was considered signifi cant. A statistical software 
package (SPSS-10; SPSS, Chicago, Ill) was used for data analysis.
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Results
Subjects
One individual did not consent to undergo MR imaging. Of the 62 family 
members who had CADASIL, 40 individuals had a mutation in the NOTCH3 
gene and 22 did not. The mean age of the 40 mutation carriers who were 
included in our study population was 45 years ± 10 (SD) (range, 21–59 years); 
21 women (mean age, 45 years ± 11) and 19 men (mean age, 46 years ± 10) 
were included. The age and sex distribution of the 40 mutation carriers are 
listed in table 1. Thirty-two of the 40 NOTCH3 mutation carriers had a mutation 
in exon 4; the remaining eight patients had mutations in exon 19, 20, 8, or 11. 
Thirty-two mutation carriers were clinically symptomatic. The symptoms varied 
in severity, ranging from one transient ischemic attack to multiple strokes and 
cognitive decline.
Characteristic 20-30 years 31-40 years 41-50 years 51-60 years
No. of patients 5 4 16 15
Sex
    M 2 2 7 7
    F 3 2 9 8
Clinical  
manifestation
    Symptomatic 0 3 14 15
    Asymptomatic 5 1 2 0
Table 1 Baseline characteristics of NOTCH3 mutation carriers according to age group
MR imaging
Figure 1 shows the prevalence of areas of hyperintensity, SLLs, lacunar 
infarcts, and microbleeds among patients of different age groups. Areas of 
hyperintensity were observed in all mutation carriers. The load of areas of 
hyperintensity as quantifi ed with the Scheltens score did not differ signifi cantly 
(P=0.5) between men (mean score, 52) and women (mean score, 48). Thirty-
two (80%) of 40 mutation carriers had lacunar infarcts, with a mean of 19 
(range, 1–60) lacunar infarcts per patient. This group of mutation carriers with 
lacunar infarcts had a mean age of 49 years ± 6 (age range, 38–59 years). 
Men had signifi cantly (P=0.01) more lacunar infarcts (n=22) than did women 
(n=9). Microbleeds were found in ten (25%) mutation carriers, with a mean 
age of 53 years ± 5 (age range, 43–58 years). Per patient, a mean of nine 
microbleeds (range, 1–35) was found. The prevalence of microbleeds did 
not differ signifi cantly (P=0.3) between men and women. Twenty-two (55%) 
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mutation carriers with a mean age of 49 years ± 8 (age range, 25–59 years) 
had SLLs. SLLs were signifi cantly (P=0.02) more prevalent in men (n=14) than 
they were in women (n=8).
Figure 2 Graph shows prevalence of areas of hyperintensity per location in relation to age. 
In patients in the 3rd decade, only supratentorial areas of hyperintensity (black bars) were 
present. With increasing age, areas of hyperintensity were found in other locations too. In 
patients in the 6th decade, almost all mutation carriers had areas of hyperintensity in every 
region. Areas of hyperintensity were observed in the following areas: thalamus (white bars), 
infratentorial region (light grey bars), and basal ganglia (dark grey bars).
Figure 1 Graph shows prevalence of areas of hyperintensity (black bars), SLLs (light grey 
bars), lacunar infarcts (white bars), and microbleeds (dark grey bars) in different age groups. 
Areas of hyperintensity were present in all mutation carriers. SLLs were found in patients in 
the 3rd decade and older; lacunar infarcts, in those in the 4th decade and older; and 
microbleeds, in those in the 5th decade and older.
Figure 2 shows the prevalence of areas of hyperintensity in different age groups 
classifi ed according to the supratentorial white matter, the infratentorial 
structures, the basal ganglia, and the thalamus. In patients in the 3rd decade, 
only areas of hyperintensity in the supratentorial white matter were present 
(fi gure 3). Areas of hyperintensity in the infratentorial structures, the basal 
ganglia, and the thalamus were present in patients in the 4th decade. In 
the 6th decade, all mutation carriers had areas of hyperintensity in each 
compartment. To further characterize the distribution of areas of hyperintensity 
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within the supratentorial white matter at different times, we subcategorized 
this compartment into several anatomic regions and assessed the presence 
of areas of hyperintensity in the different age groups (fi gure 4). In all young 
mutation carriers, subtle areas of hyperintensity in the anterior temporal lobe 
were found (fi gure 3). Although the occipital lobe was less affected in patients 
younger than 40 years as compared with other lobes, all lobes were equally 
affected in patients older than 40 years. Areas of hyperintensity in the external 
capsule were present in patients older than 30 years; areas of hyperintensity 
in the internal capsule were seen in patients older than 40 years (fi gures 5, 6). 
Frontal periventricular areas of hyperintensity and periventricular bands were 
seen in four mutation carriers; temporal periventricular areas of hyperintensity, 
in two mutation carriers; and occipital periventricular areas of hyperintensity, 
in one mutation carrier younger than 30 years. The total periventricular 
Scheltens score in this group varied between 0 and 4. In patients older than 30 
years, all mutation carriers had periventricular areas of hyperintensity in every 
region. With the exception of one mutation carrier who had a score of 3, all 
other patients had a total periventricular Scheltens score that varied between 
6 and 8, the maximal score for periventricular areas of hyperintensity.
Figure 3 Axial FLAIR MR images in NOTCH3 mutation carriers who were 20-30 years old (a-d). 
Image shows areas of hyperintensity (arrowhead in a) in the anterior temporal lobe. Image 
shows SLLs (arrowhead in b). Image shows small ventricular caps (arrowhead in c). Image 
shows small areas of hyperintensity in the semiovale centre (arrowhead in d).
 
a) b) 
c) d) 
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Figure 4 Graph shows supratentorial areas of hyperintensity distributed among the different 
regions according to age. In the 3rd decade in all mutation carriers, areas of hyperintensity 
were observed in the anterior temporal lobe. Areas of hyperintensity were found in the 
external capsule in patients in the 4th decade and older and in the internal capsule in 
patients in the 5th decade and older. Areas of hyperintensity were observed in the following 
regions: frontal lobe (black bars), occipital lobe (dotted bars), parietal lobe (diagonally 
striped bars), temporal anterior lobe (light grey bars), temporal posterior lobe (horizontally 
striped bars), internal capsule (white bars), and external capsule (dark grey bars).
Figure 5 Axial FLAIR MR images (a-c). T2*-weighted gradient-echo MR image (d). Images 
obtained in NOTCH3 mutation carriers who were 41-50 years old show confl uent areas 
of hyperintensity in all lobes (a-c). Involvement of the external capsule (arrowhead) is an 
important feature at this age. Lacunar infarcts (arrow in c) and microbleeds (arrow in d) 
are present.
 
a) b) 
c) d) 
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Of the total 606 lacunar infarcts, 249 were located in the basal ganglia; 
lacunar infarcts were also found in the frontal lobe (n=125), the parietal lobe 
(n=129), the temporal lobe (n=44), the pons (n=27), the thalamus (n=22), the 
cerebellum (n=5), the occipital lobe (n=4), and the mesencephalon (n=1). 
Only 10 (1.7%) lacunar infarcts were larger than 10 mm in diameter. Figure 
7 shows the prevalence of lacunar infarcts per location in the different age 
groups. The supratentorial lacunar infarcts were seen in patients in the 4th 
decade, and their prevalence was greater in those during the 5th decade 
(fi gures 5, 6, 8). Lacunar infarcts in the basal ganglia were present in patients in 
the 4th decade. In patients in the 5th decade, their prevalence was 81%, and 
this percentage was the same in patients during the 6th decade. In the 6th 
decade, NOTCH3 mutation carriers had lacunar infarcts in the infratentorial 
region (53%) and in the thalamus (47%).
 
a) b) 
c) d) 
Figure 6 Axial FLAIR MR images(a-c). T2*-weighted gradient-echo MR image(d). Images 
obtained in NOTCH3 mutation carriers who were 51-60 years old show complete penetrance 
of CADASIL: confl uent areas of hyperintensity (a-c), lacunar infarcts (arrows in c), SLLs 
(arrowheads), and microbleeds (arrow in d).
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Figure 7 Graph shows prevalence of lacunar infarcts per location in relation to age. In 
patients in the 4th decade, lacunar infarcts were present in the supratentorial region (black 
bars) and in the basal ganglia (dark grey bars). Lacunar lesions in the infratentorial region 
(light grey bars) and in the thalamus (white bars) were present in patients older than 40 
years.
The distribution of the total 85 microbleeds was as follows: thalamus (n=53), 
occipital lobe (n=11), temporal lobe (n=5), cerebellum (n=5), brainstem (n=4), 
parietal lobe (n=4), basal ganglia (n=2), and frontal lobe (n=1). Seventy-eight 
(92%) microbleeds were smaller than 5 mm in diameter; the largest was 10 
mm in diameter (fi gures 5, 6). The prevalence of microbleeds per location in 
the different age groups is illustrated in fi gure 9.
Discussion
The spectrum of MR imaging abnormalities in patients who have CADASIL 
has been described in several studies39-43,77,78. These abnormalities include 
areas of hyperintensity, lacunar infarcts, a characteristic pattern of SLLs, and 
microbleeds. To the best of our knowledge, this study is the fi rst to determine 
the presence of these lesions, on the basis of radiologic appearances in 
patients with CADASIL during the 3rd, 4th, 5th, and 6th decades.
As early as the 3rd decade, cerebral abnormalities can be found in patients 
who have CADASIL. In this study, supratentorial areas of hyperintensity were 
observed in all patients, and SLLs were observed in one patient. A notable 
site of predilection of the areas of hyperintensity is the anterior temporal 
lobe. These areas of hyperintensity are found in all patients of this age group, 
invariably as a highly characteristic pattern of bilateral hyperintense areas 
located directly below the cortical ribbon. Although this type of abnormality 
has been described by others as a characteristic fi nding in patients who 
have CADASIL, the early involvement of the anterior temporal lobe has not 
been reported before, to our knowledge67. A pattern of multiple, although 
often few, small patches with high signal intensity was observed in other 
locations. Periventricular white matter areas of hyperintensity are frequently 
seen as smooth caps around the frontal horns and seldom are seen around 
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the posterior and temporal horn of the lateral ventricles. In young patients, 
SLLs were another characteristic observation, and SLLs always were observed 
in conjunction with the observation of areas of hyperintensity in the anterior 
temporal lobe. SLLs are a recently described abnormality that is considered 
to be specifi c for CADASIL92. The radiologic phenomenon of SLLs is based on 
the presence of dilated perivascular spaces of perforating arteries at the level 
of the grey matter–white matter junction and spongiosis in the surrounding 
parenchyma. Detection of areas of hyperintensity with or without SLLs in the 
anterior temporal lobes in young patients is highly characteristic of fi ndings in 
young patients with CADASIL, and detection of these areas of hyperintensity 
suggests the diagnosis.
In the 4th decade, in addition to areas of hyperintensity and SLLs, lacunar infarcts 
were seen in patients who have CADASIL. These lacunar infarcts are found in 
75% of patients of this age group, and they occur in the supratentorial white 
matter and in the basal ganglia. In the supratentorial white matter, areas of 
hyperintensity in the external capsule are a new fi nding in this age group, and 
this fi nding can be observed in 25% of patients. The prevalence of subcortical 
areas of hyperintensity increases in all lobes, and larger periventricular 
areas of hyperintensity are present. Subcortical and periventricular areas 
of hyperintensity may become confl uent. The areas of hyperintensity in the 
anterior temporal lobe increase in size and expand posteriorly in the temporal 
lobe. Apart from the supratentorial white matter, areas of hyperintensity are 
now also observed in the basal ganglia, the thalamus, and the brainstem. 
Although the number of patients in whom SLLs are observed does not 
increase, the number of SLLs per patient is higher than it is in the preceding 
age group, and the distribution of SLLs follows the expanding white matter 
areas of hyperintensity of the anterior temporal lobes.
In patients in the 5th decade, microbleeds may be observed in addition to 
areas of hyperintensity, SLLs, and lacunar infarcts. Microbleeds are found in 
19% of patients in this age group, and they can be observed in the thalamus, 
the brainstem, and the supratentorial white matter. The number of patients 
in whom areas of hyperintensity are observed further increases, although 
there are still patients in whom areas of hyperintensity are not observed in 
the infratentorial white matter, in the basal ganglia, or in the thalamus. The 
number and size of areas of hyperintensity further increase, giving rise to large 
confl uent areas of high signal in subcortical and periventricular white matter. 
Areas of hyperintensity can also involve the internal capsule. The prevalence 
of lacunar infarcts (94%) and SLLs (56%) increases. Now lacunar infarcts also 
are present in the brainstem and the thalamus.
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In patients in the 6th decade, no new types of lesions are seen, and areas 
of hyperintensity, SLLs, lacunar infarcts, and microbleeds are observed in 
most patients. Areas of hyperintensity are always found in all lobes, in the 
brainstem, in the basal ganglia, and in the thalamus. In almost all cases, areas 
of hyperintensity are also found in the internal and external capsule. During 
this stage, most of the supratentorial white matter may show a symmetric 
pattern of large homogeneous areas of increased signal intensity involving 
the subcortical and periventricular white matter. Lacunar infarcts are found 
in more than 90% of cases. SLLs are found in 73% of cases; microbleeds, in 
47%. SLLs may now be observed in the temporal lobe, in the subinsular white 
matter, and in the operculum of the frontal lobe.
In patients older than 30 years, CADASIL shares several radiologic characteristics 
with other diseases accompanied by small vessel disease, which implies that 
differentiating CADASIL from these disorders based on fi ndings of radiologic 
examinations may be diffi cult. Nonspecifi c areas of hyperintensity in the 
periventricular, the frontal, the parietal, and the occipital regions are seen 
 
a) b) 
c) d) 
Figure 8 Axial FLAIR MR images obtained in NOTCH3 mutation carriers who were 31-40 years 
old. At this age, areas of hyperintensity (arrowhead in a and b) and SLLs (arrow in a) expand 
from the anterior temporal lobe posteriorly and affect the whole temporal lobe. Areas of 
hyperintensity in the semiovale centre become larger. Areas of hyperintensity in the external 
capsule (arrowhead in c) and lacunar infarcts (arrow in d) are present.
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in a number of other small vessel diseases82. Brainstem abnormalities located 
predominantly at the rostrocaudal centre of the pons are frequently observed 
in patients who have CADASIL, but they can also be found in patients who 
have atherosclerosis83. The occurrence of lacunar infarcts and microbleeds is 
also considered to be characteristic of cerebral small vessel disease in general 
and is not characteristic of only CADASIL55,84. Still, the distribution of the areas 
of hyperintensity and the presence of SLLs seem to specifi cally suggest the 
diagnosis of CADASIL. By using image post processing software that is based 
on statistical parametric mapping, Auer et al compared patterns of areas 
of hyperintensity in a group of patients who had CADASIL and a group of 
patients who had Binswanger’s disease67. In that study, it was suggested that 
the presence of white matter areas of hyperintensity in the anterior temporal 
lobe was characteristic of patients who had CADASIL. The image processing 
technique used in that study only permitted detection of differences between 
groups and did not help in determination of the diagnosis in patients. In our 
study, the characteristic areas of hyperintensity in the anterior temporal lobe 
were present in 39 of 40 patients who had CADASIL, and this result demonstrates 
that the prevalence of this fi nding in patients who have CADASIL is high, 
which makes it a useful radiologic hallmark of the disease. The presence of 
areas of hyperintensity in the external capsule also has been described to 
be characteristic of CADASIL43. Because of its high prevalence (94%) among 
patients with CADASIL after the age of 40, this is another sign that is helpful in 
the suggestion of the diagnosis later during the course of the disease. Finally, 
the prevalence of SLLs increases considerably in patients older than 40 years, 
and therefore, this lesion is helpful for detection of the disease in patients with 
increasing age.
Figure 9 Graph shows prevalence of microbleeds per location in relation to age. Microbleeds 
were present in patients older than 40 years, predominantly in the thalamus (white bars). 
Graph also shows data for those observed in the following areas: supratentorial region 
(black bars), infratentorial region (light grey bars), and basal ganglia (dark grey bars).
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In our study, men were more frequently affected by lacunar infarcts and 
SLLs than were women. For this observation, there is no simple explanation. 
A difference in age at death between men and women who have CADASIL 
has been found19. Death occurs at a signifi cantly younger age in men, and 
although this difference may refl ect the generally observed difference in life 
expectancy, it may also be caused by differences in the disease dynamics in 
men and women.
In summary, in patients who have CADASIL, imaging abnormalities are found 
in the brain earlier than expected clinically. In young patients who have 
CADASIL, cerebral abnormalities are highly characteristic, although limited. 
The areas of hyperintensity in the anterior temporal lobe and the SLLs that are 
observed in these young patients continue to help in the recognition of the 
underlying condition later in life.
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Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL) is caused by mutations in 
the NOTCH3 gene. Knowledge of disease expression in young adult 
NOTCH3 mutation carriers (MCs) is limited. The aim of the study was to 
characterize clinical, neuropsychological, and radiological status in 
NOTCH3 MCs younger than 35 years.
Individuals younger than 35 years who were at a 50% risk of a 
NOTCH3 mutation, from our CADASIL database. Thirteen individuals, 
from 8 families, met the criteria. NOTCH3 mutation carriership was 
determined in these individuals after completion of clinical, genetic, 
neuropsychological, and radiological investigations in order to be 
able to compare mutation carriers (MCs) to non mutation carriers 
(NMCs) in a double-blinded setting. Magnetic resonance images were 
scored according to a standardized white matter hyperintensities 
rating scale.
Six individuals, from fi ve families, were MCs. Clinical symptoms 
consisted of migraine (with aura), stroke, and stroke like episodes. We 
did not fi nd evidence for psychiatric disturbances, functional disability, 
or cognitive dysfunction, compared with non-MCs. Radiologically, a 
characteristic magnetic resonance imaging lesion pattern emerged 
for all MCs. This comprised white matter hyperintensities in the anterior 
temporal lobes, the frontal lobes, and the periventricular frontal 
caps.
In conclusion migraine (with aura) and stroke can present in NOTCH3 
MCs younger than 35 years; however, more importantly, physical 
function and cognition are intact. Possible subtle cognitive dysfunction 
needs to be assessed in a larger study. White matter hyperintensities on 
magnetic resonance imaging are characteristic, and are consistently 
visualized from the age of 21 years and onward. Awareness of the 
clinical and radiological features of CADASIL in those younger than 
35 years should increase early diagnosis and allow for customized 
counselling of young adults from families with CADASIL.
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Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is a hereditary microangiopathy caused by 
mutations in the NOTCH3 gene19. Distinctive ultrastructural granular osmiophilic 
material in the vascular media and degeneration of vascular smooth muscle 
cells compose the pathological hallmark51,85. The clinical diagnosis of CADASIL 
is considered in patients with otherwise unexplained central nervous system 
symptoms, extensive white matter changes with or without subcortical 
infarctions on magnetic resonance (MR) imaging, and a family history of 
neurological disorders10. The disease presentation and natural history are 
diverse, but, typically, the diagnosis is made in the fi fth decade of life when 
mutation carriers (MCs) present with recurrent stroke like episodes and/or 
cognitive decline. Up to 40% of persons diagnosed as having the disease 
have a history of migraine with aura, with onset in their mid-20s. Psychiatric 
disturbances can play a role in about a third of affected individuals10.
CADASIL is considered a late-onset hereditary disease, with a mean age 
at onset of 45 years8. Abnormalities on MR imaging are present before the 
onset of clinical symptoms, and it is generally accepted that by the age of 
35 years, all NOTCH3 MCs have white matter hyperintensities (WMHs) to some 
extent6,8,86. Although several studies have included clinical or radiological, 
reports of asymptomatic MCs, these studies did not focus specifi cally on 
young adults8,10,39,42,87. This prompted us to prospectively study the clinical, 
neuropsychological, and radiological profi les of individuals younger than 35 
years who were at a 50% risk of a NOTCH3 mutation. We expect that more 
insight into the clinical and radiological aspects of CADASIL in young adults 
will improve early diagnosis in this age group and allow for more tailored 
counselling of asymptomatic young adults at risk for CADASIL.
Materials and methods
Subjects
Individuals participating in the study gave informed consent, and the medical 
ethics committee of the Leiden University Medical Centre approved the 
study. All those younger than 35 years who were at a 50% risk of being a 
carrier, irrespective of signs and symptoms, were selected from a database 
of 15 families with CADASIL who had a known NOTCH3 mutation; these 
families were participating in an ongoing study of CADASIL in the Netherlands. 
Individuals younger than 18 years were not included for ethical reasons. The 
database included 63 symptomatic and asymptomatic individuals, of whom 
13 met the inclusion criteria for the present study. These 13 individuals were 
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members of 8 unrelated families, with varying mutations in the NOTCH3 gene. 
Clinical, neuropsychological, and radiological examinations were completed 
before mutation analysis. Consequently, examiners (SAJLO, YMK, HAMM, and 
MAvB) and participants were blinded to carrier status. Mutation analysis was 
performed according to previously described techniques22. Before the study 
commenced, it was agreed with participants that the results of mutation 
analysis and an MR examination would not be disclosed. Counselling was 
performed by an independent genetic counsellor for those individuals who 
requested presymptomatic testing.
Clinical data
We obtained a full medical history from all participants and obtained 
their medical records from their physicians and general practitioners. In a 
semistructured interview, specifi c questions were asked pertaining to possible 
undocumented past episodes of focal neurological defi cits, migraine 
(with aura), and psychiatric history. Criteria for migraine were maintained 
according to the international Headache Classifi cation Committee88. All 
participants completed a structured questionnaire concerning the presence 
of cardiovascular disease–related risk factors and drug use. The questionnaire 
included questions about nicotine and alcohol abuse, body weight and 
height, and history of hypercholesterolemia, hypertension, and diabetes 
mellitus. These conditions were defi ned as previously described76. Disability 
at the time of the study was measured semiquantitatively with the Rankin 
scale score, which ranges from 0 (no symptoms at all) to 5 (severe disability 
requiring constant nursing). Depression and anxiety were measured with the 
Hospital Anxiety and Depression Scale (HADS)89,90. The HADS is a 4-point, 14-
item, self-assessment instrument developed for detecting levels of depression 
and anxiety in the setting of a hospital outpatient clinic. The global outcome 
measure was used, with a cut-off score of 13, because this is more appropriate 
than the anxiety and depression subscores in samples with minor psychiatric 
disorders91.
MR imaging
A uniform MR imaging protocol was performed on a 1.5-T MR imaging system 
(Philips Medical Systems, Best, the Netherlands) on the same day as the 
neuropsychological testing. The same neuroradiologist (MAvB), blinded to 
clinical and genetic data, reviewed all MR scans. Labelling MR scans with a 
number, instead of patient name and age, further ensured blinded scoring. 
The MR imaging protocol and grading of WMHs and lacunar infarctions were 
performed as previously described76. In brief, T1-weighted spin-echo, dual T2-
weighted turbo spin-echo, and  fl uid-attenuated inversion recovery images 
were obtained in the axial plane. White matter hyperintensity lesion load was 
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graded according to the validated signal hyperintensities’ rating scale of 
Scheltens et al59. In this scale, the brain is anatomically divided into deep white 
matter, basal ganglia, and infratentorial regions. For each region, a score of 
0 to 6 is assigned according to the following scale: 0, absent; 1, up to 5 WMHs 
with less than a 3-mm diameter; 2, 6 or more WMHs with less than a 3-mm 
diameter; 3, up to 5 WMHs with a 4- to 10-mm diameter; 4, 6 or more WMHs 
with a 4- to 10-mm diameter; 5, 1 or more WMHs with a greater than 10-mm 
diameter; and 6, confl uent hyperintensity. In addition, frontal and occipital 
periventricular “caps” and periventricular “bands” are scored as follows: 0, 
absent; 1, up to 5 mm; and 2, greater than 5 mm. We also scored WMHs in 
the external capsule region, which is not normally included in the scale of 
Scheltens et al. We did not include this subscore in the total WMHs score. The 
presence of subcortical lacunar lesions, considered specifi c for CADASIL, was 
recorded92.
Neuropsychological evaluation
All individuals followed a standardized neuropsychological test battery, 
lasting 3 hours. Details regarding administration, scoring, and clinical value of 
the administered neuropsychological tests have been extensively described 
by Spreen and Strauss123. Global cognitive functioning was assessed using the 
Cambridge Cognitive Examination, which incorporates the Mini-Mental State 
Examination94. The Cambridge Cognitive Examination provides a total score 
for global cognitive functioning and subscores for specifi c cognitive functions 
(memory, orientation, language, praxis, and gnosis). In addition, memory was 
evaluated using the Wechsler Memory Scale. Tests of executive functioning 
included the Trail-Making Test B, the Stroop colour and word test, the digit 
symbol subtest of the Wechsler Adult Intelligence Scale–Revised, and verbal 
and category fl uency. For data analysis, the raw scores of the tests were used, 
except for the Wechsler Memory Scale memory quotient and the digit symbol 
subtest score, which were conventionally transformed into scaled scores123.
Statistical analysis
Statistical analysis was performed using the SPSS software package, version 
10 (SPSS Inc, Chicago, Ill). Differences in mean test results between MCs and 
non-MCs (NMCs) were analyzed with the Student t-test.
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Results
Subjects and clinical data
Of the 13 individuals at 50% carrier risk, 6 were NOTCH3 MCs. These 6 individuals 
came from 5 unrelated families. The mutations were as follows: Arg141Cys 
(n=2), Arg153Cys (n=1), Arg182Cys (n=2), and Arg1076Cys (n=1). The mean 
± SD age of the 6 MCs (2 men and 4 women) was 24.67 ± 4.32 years (range, 
21-31 years), and that of the 7 NMCs (6 men and 1 woman) was 27.14 ± 
3.80 years (range 22-33 years). Age (P=0.30) and sex (P=0.06) did not differ 
signifi cantly between MCs and NMCs. None of the participants had visited 
a physician with symptoms leading to a diagnosis of CADASIL before the 
study, and none recalled any obvious episodes of focal neurological defi cit 
with sudden onset. However, 2 individuals described aspecifi c episodes of 
sudden focal neurological defi cits. In one individual (patient number [PN] 6), 
this involved speech disturbances lasting less than 1 minute, since roughly the 
age of 25 years; the other individual (PN 3) had experienced several weeks 
of blurred vision in late adolescence. Although both of these individuals had 
migraine with aura, these episodes did not resemble their usual auras, nor 
were they associated with headache. Both were MCs. A third MC (PN 4) had 
a confi rmed stroke, consisting of sudden dysphasia and unilateral hand and 
tongue paresthesia, shortly after the study, at the age of 26 years. A total 
of 3 MCs (1 man and 2 women) had migraine, and 2 had migraine with 
aura. In one individual (PN 6), attacks started in the late 20s and consisted 
of typical visual aura followed by headache. The other individual (PN 3) 
had visual, sensory, and aphasic aura followed by unilateral headache, 
photophobia, phonophobia, and vomiting, with attacks clustering in the fi rst 
3 years of adolescence. The third individual (PN 1) had had several migraine 
attacks without aura, also clustering in early adolescence. At the time of the 
study, no focal neurological defi cits were clinically observed in any of the 
participants. The Rankin scale score was 0 (no disability at all) for all MCs and 
NMCs. Cardiovascular risk factors were present as follows: diabetes mellitus, 
hypertension, and alcohol abuse in 0 MCs and NMCs; smoking in 4 of 7 NMCs 
and in 0 MCs (P=0.02); and hypercholesterolemia in 1 of 7 NMCs and in 0 MCs 
(P=0.38). The body mass index was not increased in either MCs or NMCs. Two 
MCs and 1 NMC had a history of minor depression in their early 20s, for which 
psychological help was sought. One NMC and 0 MCs had a global HADS 
score higher than 13. The mean ± SD global HADS score for MCs was 5.1 ± 3.8; 
and for NMCs, 7.4 ± 6.3 (P=0.46).
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MCs (n=6) NMCs (n=7) P
Variable 1 2 3 4 5 6 1 2 3 4 5 6 7
Age, y ≤23 ≤23 ≤23 ≤26 ≤29 ≤32 ≤23 ≤23 ≤29 ≤29 ≤29 ≤32 <35 .3
Periventricular 
WMHs (0-2)
Caps
Frontal 0 1 1 2 2 2 0 0 0 0 0 0 0 .001
Occipital 0 0 0 0 1 1 0 0 0 0 0 0 0 .10
Bands: lateral 
ventricles
0 1 1 1 1 2 0 0 0 1 1 1 1 .20
Sum score (0-6) 0 2 2 3 4 5 0 0 0 1 1 1 1 .01
Subcortical WMHs 
(0-6)
Frontal 1 3 0 4 3 6 0 0 0 0 0 3 0 .02
Parietal 0 0 0 3 3 6 0 0 0 0 0 0 0 .05
Occipital 0 0 0 6 0 0 0 0 0 0 0 0 0 .30
Temporal 3 5 5 3 3 6 0 0 0 0 0 0 0 <.001
Sum score (0-24) 4 8 5 16 9 18 0 0 0 0 0 3 0 .001
Basal ganglia 
WMHs (0-6)
Caudate nucleus 0 0 0 0 0 0 0 0 0 0 0 0 0 NA
Putamen 0 0 0 0 0 0 0 0 0 0 0 0 0 NA
Globus pallidus 0 0 0 0 0 0 0 0 0 0 0 0 0 NA
Thalamus 0 0 0 0 0 1 0 0 0 0 0 0 0 .30
Sum score (0-36) 0 0 0 0 0 1 0 0 0 0 0 0 0 NA
Internal capsule 0 0 0 0 0 0 0 0 0 0 0 0 0 .30
External capsule 
region†
0 0 0 1 0 1 0 0 0 0 0 0 0 .10
Infratentorial WMHs 
(0-6)
Cerebellum 0 0 0 0 0 0 0 0 0 0 0 0 0 NA
Mesencephalon 0 0 0 0 0 0 0 0 0 0 0 0 0 NA
Pons 0 0 0 0 0 5 0 0 0 0 0 0 0 .30
Medulla 0 0 0 0 0 0 0 0 0 0 0 0 0 NA
Sum score (0-24) 0 0 0 0 0 5 0 0 0 0 0 0 0 .30
Total WMHs Score 4 10 7 19 13 29 0 0 0 1 1 4 1 .004
Table 1 WMHs scores in MCs and NMCs younger than 35 years
MCs = mutation carriers, NMCs = . non-mutation carriers, WMHs = white matter hyperintensities. 
To ensure patient confi dentiality, sex was not specifi ed for each patients individually.† The 
subscore for this region was not included in the total WMHs score because WMHs in this\
region are not normally included in the scale of Scheltens et al.
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MR imaging
Table 1 shows an overview of WMHs scores according to Scheltens et al.59 
The mean ± SD total WMHs score in MCs was 13.67 ± 9.10 (range, 4-29), vs. 
1.00 ± 1.40 (range, 0-4) in NMCs (P=0.004). None of the MCs or NMCs had 
(subcortical) infarctions on MR imaging. One MC had subcortical lacunar 
lesions, abutting temporal lobe WMHs.
Table 2 Neuropsychological test results
Cognitive Domain Measure MCs (n = 6) NMCs (n = 7)
Global cognitive 
functioning
CAMCOG 99 (1) 94 (3)
MMSE 30 (1) 29 (1)
Memory CAMCOG memory 23 (1) 22 (1)
WMS memory quotient 116 (8) 108 (11)
WMS verbal memory 11 (3) 9 (2)
WMS picture memory 12 (1) 12 (1)
Language CANCOG language 29 (1) 27 (2)
Praxis CAMCOG praxis 12 (1) 11(1)
Gnosis CAMCOG gnosis 10 (0) 10 (0)
Executive functioning word fl uency (animals) 56 (8) 42 (14)
category fl uency (animals) 24 (2) 22 (4)
TMT b (seconds) 49 (10) 76 (27)
TMS B (errors) 0.1 (0.4) (0.4)
Stroop colour/word (seconds) 71 (4) 87 (16)
Stroop colour/word (errors) 0 (0) 1 (1)
 Stroop interference (s) 23 (6) 30 (12)
digit symbol (seconds) 63 (13) 57 (10)
Data are presented as mean (SD). CAMCOG = Cambridge Cognitive examination; 
MMSE = mini mental state examination; WMS = Wechsler Memory scale; TMT = Trail 
Making Test. T-test did not reveal any signifi cant (P<0.01) differences between mutation 
carriers (MCs) and non-mutation carriers (NMCs)
A distinct pattern of WMHs emerged in MCs, consisting of deep WMHs of the 
temporal lobes (6 of 6 individuals), frontal lobes (5 of 6 individuals), and frontal 
periventricular caps (5 of 6 individuals). Figure 1 shows MR scan results. The 
WMHs of the temporal lobe were specifi cally located in the anterior pole. Next 
to being present in all MCs, temporal lobe WMHs were also the most extensive, 
with a mean ± SD WMHs score of 4.20 ± 1.30 (range, 3-6), followed by a score 
of 2.80 ± 2.14 (range, 0-6) for the frontal lobe. Basal ganglia and infratentorial 
WMHs were seen only in the MC older than 30 years (table 1). Two MCs had 
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WMHs in the external capsule region. Periventricular bands were seen in 5 
of 6 MCs, but these were also relatively frequent in NMCs (4 of 7 individuals). 
One NMC had a frontal subcortical WMHs that could be attributed to head 
trauma experienced 1 year previous to the present MR investigation.
 
a) b) c) 
d) e) f) 
Figure 1 FLAIR MR images of 2 mutation carries(a-c, d-f respectively). Axial slices are shown 
through the level of the temporal lobes, the basal ganglia, and the centrum semiovale in 
individuals ages 21 and 31 years. In both individuals, hyperintensities are seen in the anterior 
temporal lobe (arrowheads in a and d), and both have frontal caps. Imaging of the 31-year 
old individual illustrates the typical pattern of frontal lobe hyperintensities that can be seen 
in CADASIL mutation carriers younger than 35 years
Neuropsychological evaluation
The neuropsychological test results are represented in table 2. The MCs 
and NMCs did not differ in mean years of education after primary school (8 
and 7 years, respectively) or in level of education. There was no signifi cant 
difference in global or specifi c neuropsychological functioning between MCs 
and NMCs.
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Discussion
The aim of this study was to learn more about the status of young adult NOTCH3 
MCs. Clinical, neuropsychological, and radiological data were compared 
between NOTCH3 MCs and NMCs younger than 35 years, in a setting blinded 
to MC status. Inherent to the study of a subgroup with a comparatively rare 
disease, this study was hampered by a relatively small study population. 
However, to our knowledge, it is the fi rst to simultaneously and comprehensively 
study all relevant disease features in this age group. Furthermore, the lack in 
numbers is partially compensated by the multipedigree background of the 
participants and the presence of a highly representative control group of 
family members without a NOTCH3 mutation. Follow-up of this patient cohort 
will be performed, and should provide further knowledge of the natural history 
of disease in young NOTCH3 MCs.
The main result is that there was no quantifi able physical or cognitive 
impairment in young adult NOTCH3 MCs. Disease expression was confi ned 
to migraine (with aura) and, less frequently, stroke. The MR scans showed a 
characteristic pattern of early WMHs. Migraine (with aura) was more common 
in MCs than in NMCs (3 of 6 vs. 0 of 7 individuals) presenting in the second and 
third decades of life. This confi rms that migraine (with aura) can be an early 
disease manifestation of CADASIL8,10,95. Stroke presented in 1 MC at the age 
of 26 years (shortly after the study), and 2 MCs described atypical episodes 
of immediate-onset focal neurological defi cits, of possible ischemic origin. In 
2 multifamily studies of the CADASIL phenotypic spectrum, ischemic episodes 
are reported to occur at the mean ± SD ages of 49.3 ± 10.7 years5 and 46.1 ± 
9.0 years (range, 30-66 years)10. However, from this study population, and from 
our clinical experience, we fi nd that transient ischemic attacks and stroke 
can already present in the third decade of life, although most do not lead to 
permanent dysfunction. There were no psychiatric disorders, as defi ned by the 
medical history and the HADS score. The age at onset of psychiatric disorders 
in individuals with CADASIL has not been defi ned, but from our results, we 
conclude that these are not present before the age of 35 years. An extensive 
neuropsychological assessment did not reveal any differences in cognitive 
function between MCs and NMCs. Taillia et al studied neuropsychological 
function in 8 individuals without dementia, aged 35 to 66 years, who had 
neurologically symptomatic CADASIL, and found subtle cognitive impairment 
in all, specifi cally in tasks involving the frontal lobes96. We did not fi nd any 
dysfunction concerning these executive tasks, or any other tasks, in those 
younger than 35 years. The age of 35 years, therefore, may be the lower age 
limit at which neuropsychological dysfunction can begin to become manifest. 
Possible subtle cognitive changes in this age group need to be assessed in a 
larger follow-up study.
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The MR imaging abnormalities in young adult NOTCH3 MCs, although 
relatively subtle in the early 20s, were consistently present much earlier than 
the maintained age of 30 to 35 years8,86. Furthermore, the MR lesion pattern 
proved to be distinct, with landmark features being anterior temporal lobe 
WMHs, frontal lobe WMHs, and frontal caps. Temporal lobe lesions were 
present in all MCs, with a WMHs score between 3 and 6, corresponding to 
the presence of at least 1 lesion of 4 mm in diameter. The scale of Scheltens 
et al does not refl ect the sublocation of WMHs within the cerebral lobes, 
but we observed that the temporal lobe lesions were specifi cally located 
anteriorly59. In the general population with CADASIL, temporal lobe WMHs 
are often, but not always, present (sensitivity, 95%; and specifi city, 80%)43. 
Frontal caps and frontal deep WMHs were seen in 5 of 6 MCs, although the 
latter were not specifi c for MCs, because one NMC also had frontal WMHs. 
Another nonspecifi c MR imaging feature was lateral periventricular bands, 
which were observed in MCs and NMCs. Subcortical lacunar lesions, although 
apparently infrequent in individuals younger than 35 years (1 of 6 MCs), are 
a specifi c sign for CADASIL92. Overall, our MR fi ndings correspond with those 
of recent studies describing periventricular, temporal pole, frontal lobe, and 
external capsule region WMHs as radiological markers in (older) patients with 
CADASIL39,41,43. White matter hyperintensities in older patients, however, are 
much more extensive, with the heaviest lesion load in the frontal lobes,24 
constituting a visually altogether different MR result from the one we observed 
in young MCs41. Furthermore, contrary to what has been previously suggested, 
we did not fi nd external capsule region WMHs to be a distinguishing feature 
early in the radiological disease process43. We have no clear-cut answer 
as to why CADASIL-related WMHs initiate in the temporal and frontal lobes. 
Apparently, certain vessels may be more susceptible to CADASIL-related 
vasculopathy than others, possibly for reasons of calibre or length43. At any 
rate, acquaintance with the WMHs lesion pattern and load in those younger 
than 35 years should be an important means of recognizing CADASIL in this 
age group, especially in the differential diagnosis of multiple sclerosis, which 
can mimic the signs and symptoms of CADASIL49,97. Once the diagnosis of 
CADASIL is considered based on clinical and neuroimaging data, NOTCH3 
mutation analysis or pathological examination of a skin biopsy specimen is 
required to confi rm the diagnosis66,98.
Familiarity with the clinical and neuroimaging features of CADASIL in young 
adults should promote early diagnosis and prevent misdiagnosis and needless 
(invasive) diagnostic or therapeutic procedures.
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Abstract
Purpose was to study whether there is a difference in magnetic 
resonance (MR) lesion pattern between young patients with cerebral 
autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) and multiple sclerosis (MS).
The presence of lacunar infarcts, microbleeds, subcortical lacunar 
lesions, and white matter hyperintensities (WMHs) in the anterior 
temporal lobe and the external and internal capsule was assessed 
on MR images. Images were obtained in 24 CADASIL patients and 19 
MS patients under the age of 50 years, comprising T1-weighted, dual 
fast spin-echo, fl uid attenuated inversion recovery (FLAIR), and T2*-
gradient-echo images in the axial plane. Differences were assessed 
with the Fisher’s exact test. 
CADASIL patients showed signifi cantly more subcortical lacunar 
lesions, lacunar infarcts, and hyperintensities in the anterior temporal 
lobe and the external capsule compared with MS. The presence 
of WMHs in the internal capsule and microbleeds did not differ 
signifi cantly between the patient groups. 
Based on the presence and pattern of abnormalities observed on 
MR images of CADASIL patients, young CADASIL patients can be 
discriminated from young patients with MS. 
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Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leucoencephalopathy (CADASIL) is a late-onset hereditary syndrome 
caused by mutations in the NOTCH3 gene19. The pathological substrate is a 
microangiopathy characterized by distinctive granular osmiophilic material 
in the vascular media, leading to degeneration of vascular smooth muscle 
cells7. The disease is clinically characterized by initially attacks of migraine 
with aura (<age 30) and later on (>age 40) transient ischemic attacks, strokes, 
progressive subcortical dementia, and mood disturbances8. The radiological 
hallmarks of CADASIL are the presence on magnetic resonance (MR) imaging 
of white matter hyperintensities (WMHs) with a specifi c distribution, and lacunar 
infarcts, subcortical lacunar lesions, and microbleeds39-41,43,76,77,92. Recently we 
described that these lesions develop in a predictable way during the course 
of the disease78. As early as in the third decade of life subcortical lacunar 
lesions and patchy WMHs usually located in the anterior temporal lobe can be 
found whereas in the sixth decade a full-blown picture with confl uent WMHs, 
subcortical lacunar lesions, lacunar infarcts, and microbleeds is observed in 
most patients.
Whereas the radiological picture of advanced stages of CADASIL is well 
documented, and can usually be discriminated from Binswanger’s disease, 
the radiological appearance at earlier stages of CADASIL may mainly 
comprise only of WMHs, similar to those found in multiple sclerosis (MS)67. As 
MS may also have a similar clinical presentation as CADASIL many CADASIL 
patients are misdiagnosed as MS49,50. Here we compared the cerebral MR 
pictures of relatively young CADASIL patients with those of age-matched MS 
patients in order to identify radiological features that may help to discriminate 
CADASIL already at the early stages from MS. 
Materials and methods
Subjects
We included 24 patients (<50 years) with proven NOTCH3 mutations from 15 
unrelated Dutch CADASIL families, participating in our ongoing prospective 
study on clinical, radiological and genetic aspects of CADASIL22. These 
patients were compared with 19 age-matched patients with laboratory-
supported defi nite MS who were recruited from the authors’ institution99. Only 
subjects who were able to understand the informed consent were included 
and informed consent was obtained from all subjects. The medical ethics 
committee of our institution approved the study protocol. 
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MR imaging
All MR examinations were performed on a 1.5T MR system (Philips Medical 
systems, Best, The Netherlands). All participants were subjected to the same 
standardized MR protocol, comprising: conventional T1-weighted spin echo 
images (slice thickness 6 mm with a 0.6 mm interslice gap [6.0/0.6 mm], 
repetition time [TR]/echo time [TE] 600/20 ms, matrix 256x205, and a 220x165 
mm fi eld of view [FOV]), dual T2-weighted fast spin echo (FSE) images (3.0/0.0 
mm, TR/TE 3000/27/120 ms, matrix 256x205, FOV 220x220 mm), and fast fl uid-
attenuated inversion recovery (FLAIR) images (3.0/0.0 mm, TR/TE 8000/100 ms, 
inversion time 2000 ms, matrix 256x192, FOV 220x176 mm). In addition, T2*-
weighted gradient echo planar (EPI) sequence (6.0/0.6 mm, TR/TE 2598/48 
ms, matrix 256x192, FOV 220x198 mm, EPI factor 25) were performed to detect 
haemosiderin deposits. All images were performed in the axial plane parallel 
to the inferior border of the genu and splenium of the corpus callosum.
Visual rating 
Two radiologists (MAvB, RvdB) blinded to the diagnosis of CADASIL and 
MS assessed for each patient the presence of the radiological hallmarks 
of CADASIL: lacunar infarcts, microbleeds, subcortical lacunar lesions, and 
WMHs in the anterior temporal lobe, the external and internal capsule. 
Lacunar infarcts were defi ned as parenchymal defects not extending to the 
cortical grey matter with a signal intensity following that of cerebral spinal 
fl uid (CSF) on all pulse sequences, irrespective of size (fi gure 1). In an effort 
to differentiate lacunar infarcts from dilated perivascular spaces, areas 
that were isointense to CSF on all pulse sequence and located in the lower 
one-third of the corpus striatum, were excluded80,100. Subinsular perivascular 
spaces were differentiated from lacunar infarcts based on the description of 
Song et al: enlarged perivascular spaces have a featherlike confi guration, 
are isointense to CSF on T2- and T1-weighted images, but do not have high 
signal on FLAIR images73. In an effort to differentiate perivascular spaces along 
the perforating arteries from lacunar infarcts a modifi cation of the descriptive 
criteria for perivascular spaces as used by Bokura et al was applied: all 
lesions with a transverse diameter smaller or equal to 2 mm or with a tubular 
appearance following the course of perforating arteries were most likely to 
represent perivascular spaces and were excluded as well81.
Microbleeds were defi ned as focal areas of signal loss on T2-weighted FSE 
images that increased in size on the T2*-weighted gradient echo pulse 
sequence (“blooming effect”) (fi gure 1)76. In this way, microbleeds were 
differentiated from areas of signal loss based on vascular fl ow voids. Areas of 
symmetric hypointensity of the globus pallidus likely to represent calcifi cation 
or nonhemorrhagic iron deposits were excluded.
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Subcortical lacunar lesions were defi ned as linearly arranged groups of 
rounded, circumscribed lesions just below the cortex, at the grey-white matter 
junction with a signal intensity that was identical to that of CSF on all pulse 
sequences (fi gure1)92. 
WMHs were defi ned as white matter areas with increased signal intensity on 
dual and FLAIR weighted images without mass effect. The border between 
anterior and posterior temporal lobe was defi ned as the posterior margin of 
the amygdale (fi gure1)43.
Group comparison with automated statistical image analysis tool
WMH volume (in ml) measurements were performed using locally developed 
automated segmentation software (Sniper®, Department of Radiology, 
Division of Image Processing, Leiden University Medical Centre, Leiden, The 
Netherlands). Volume of WMHs was corrected for total brain volume by 
dividing the individual volume of WMHs by intracranial volume and expressed 
in percent. WMHs detection approach consisted of three main steps:
1. Brain stripping: An average proton density image (from the Montreal 
Neurological Institute (MNI)) is fi rst co-registered to the proton density image 
of a subject using a multi-resolution 12-parameter affi ne registration. The 
standard deviation of ratio images was used as cost function. The resulting 
transformation matrix is used to resize an intracranial prior probability map 
in order to mask automatically non-brain voxels (skin, bone and eyeballs). 
A prior probability map of white matter (from MNI) is aligned using the 
same transformation matrix to guide the detection of the WMHs. For a more 
accurate intracranial delineation, fuzzy clustering, mathematical morphology 
and region growing, are applied and constraint to remain within the resliced 
intracranial mask. This step takes on average less than 1 minute per scan. 
2. CSF detection: The FLAIR image is fi rst co-registered to the T2-weighted 
image. A ratio image (FLAIR/T2) is then computed after rescaling the FLAIR 
voxel-intensity range to that of the T2-weighted image. The CSF is extracted 
in this ratio image using fuzzy clustering (c=2). The voxels belonging to the 
cluster with the darkest signal intensities within the intracranial mask are 
classifi ed as CSF. 
3. Lesion detection: The voxels of the T2-weighted image and those of the 
FLAIR image are clustered in 3 clusters. A voxel is labelled as WMH if it fulfi ls 
three conditions: (i) Its T2 intensity belongs to the brightest cluster and it 
does not intersect with the CSF mask detected in step 2; (ii) its FLAIR intensity 
belongs to the brightest cluster; (iii) it has a relatively high probability (>0.4) 
to belong to the white matter (using the aligned white matter map). Finally 
fi gure 2 shows at the level of the anterior temporal lobe and the external 
and internal capsule for every voxel whether WMHs were present at these 
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locations, in bleu for CADASIL, in red for MS. The brighter the colour the more 
frequently WMHs were found in that location. As background we used a 
normalized T1-weighted image.
Statistical analysis
Descriptive statistics were calculated for differences in age and sex between 
CADASIL and MS patients. Differences in presence of subcortical lacunar 
lesions, lacunar infarcts, microbleeds and hyperintensities in the anterior 
temporal lobe, the external and internal capsule between CADASIL and 
MS patients were assessed with the Fisher’s exact test. Differences in WMH 
volume was assessed with a Student t-test for unpaired data. To compensate 
for multiple comparisons, we considered a P-value of P<0.005 as signifi cant. 
The agreement between the two readers was determined with Cohen’s K. 
The statistical package SPSS-10 (SPSS, Inc) was used for data analysis.
Table 1 Characteristics of the CADASIL and MS patients
Study group Subjects (n) Age (y) Sex (n)
Mean ± SD Range Men Women
CADASIL 24 40 ± 10 21-50 10 14
MS 19 42 ± 9 26-53 4 15
Table 2 Presence of MR lesions in CADASIL and MS patients
CADASIL (n=24) MS (n=19) P value
Subcortical lacunar infarcts (n) 9 0 0.002*
Lacunar infarcts (n) 15 0 <0.001*
Microbleeds (n) 4 0 0.12*
Anterior temporal lobe (n) 23 1 <0.001*
External capsule (n) 14 0 <0.001*
Internal capsule (n) 15 1 0.04*
Volume of WMHs (mean %) 4.5% 0.7% <0.001**
*Fischer exact test
** Student t-test
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Results
Subjects
Table 1 gives an overview of the characteristics of the CADASIL and MS 
patients. There were no signifi cant differences in age (Student-t test, P=0.57) 
and sex (Fisher’s exact, P=0.20) between CADASIL and MS patients. 
Visual rating 
The interobserver agreement was high for all MR imaging abnormalities 
(Kappa=0.88-1). The presence of subcortical lacunar lesions, lacunar infarcts, 
microbleeds and hyperintensities in the anterior temporal lobe, the external 
and internal capsule in CADASIL and MS patients are given in table 2. The 
following radiological features were signifi cantly higher in patients with 
CADASIL compared with those with MS (Fisher’s exact test, P<0.005): subcortical 
lacunar lesions, lacunar infarcts, and hyperintensities in the anterior temporal 
lobe and the external capsule (table 2). Although microbleeds were absent 
in MS patients, only four CADASIL patients had microbleeds and therefore no 
statistically difference was found between the two diseases. There was one 
MS patient with hyperintensities in the internal capsule. In CADASIL, WMHs in 
the internal capsule were seen in 15 patients. This radiological hallmark also 
did not reach signifi cance. 
 
a) b) c) 
Figure 1 Axial FLAIR (a-b)  and T2*-weighted (c) MR images of CADASIL patients. Complete 
MR spectrum of CADASIL: lacunar infarcts (arrow in a), subcortical lacunar lesions (arrow in 
b) and microbleeds (arrow in c).
Group comparison with automated statistical image analysis tool
As shown in fi gure 2, there is a difference in WMHs distribution between CADASIL 
and MS patients. Also, the volume of WMHs, corrected for intracranial volume 
was signifi cantly higher in CADASIL (mean 4.5%, SD 3.7) as compared with MS 
patients (mean 0.7%, SD 1.1, Student t-test, P<0.001, table 2). 
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Discussion
We compared brain MR images of young patients with CADASIL with those of 
patients with MS and found signifi cant differences with respect to the volume 
and distribution of WMHs and the presence of concomitant lesions. MR images 
of young CADASIL patients revealed a signifi cantly higher load of WMHs and 
a characteristically higher prevalence of WMHs in the anterior temporal lobe 
(23/24 in CADASIL versus 1/19 in MS) and the external and internal capsule 
(14-15/24 in CADASIL versus 0-1/19 in MS). The results show that involvement 
 
a) b) 
c) d) 
Figure 2 Frequency maps of the distribution of WMHs generated with automated statistical 
image analysis tool. Areas where WMHs occurred are displayed in colour; the brighter the 
colour, the higher the frequency of WMHs in these locations. The distribution of the WMHs in 
the CADASIL group is shown left (a and c) and in the MS group right (b and d) at the level 
of the anterior temporal lobe (a and b) and the external and internal capsule (c and d). 
Almost no WMHs were seen in the anterior temporal lobe, and internal and external capsule 
in MS patients whereas WMHs were more often present in these locations in the CADASIL 
population.
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of the anterior temporal lobe is not only a useful radiological hallmark to 
differentiate CADASIL from Binswanger’s disease in elderly patients but also to 
differentiate CADASIL from MS in younger patients67.
In addition to a characteristic pattern of WMHs, the spectrum of MR 
abnormalities in CADASIL patients also comprises lacunar infarcts, subcortical 
lacunar lesions, and microbleeds which were not found in any of our MS 
patients. 
A potential limitation of our study may be that we did not exclude CADASIL 
in our MS cases by routine screening for NOTCH3 mutations because of the 
elaborate and costly nature of the procedure. However, by using the most 
restricted POSER criteria, namely the laboratory-supported defi nite MS, we 
reduced the chance of misclassifying MS patients99. In any case, if we would 
have erroneously misclassifi ed a CADASIL patient as a MS patient, this would 
have decreased the differences we found between the two patient groups.
In this study, our goal was to assess whether the presence or absence of the 
radiological hallmarks of CADASIL helped differentiating young CADASIL 
and MS patients. In other studies MR criteria suggestive of MS have been 
defi ned. These MR criteria for MS help further strengthening the diagnostic 
confi dence of differentiating CADASIL from MS. MS frequently involves the 
spinal cord, while spinal cord lesions are virtually absent in CADASIL43,44. 
WMHs in the subcortical U fi bers suggest MS, whereas these fi bers are 
spared in CADASIL40,101. The periventricular lesions in MS are frequently ovoid 
and orientated perpendicular to the lateral ventricles which has not been 
observed in CADASIL102. Gadolinium enhancement of the WMHs frequently 
occurs in MS, and has not been described in CADASIL patients41,103. 
CADASIL can be differentiated radiologically from MS already at the young 
age, primarily on the basis of WMHs in the anterior temporal lobe and the 
external and internal capsule.
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Abstract
Apolipoprotein E (apoE) genotype plays an important role in the 
development, maintenance, and response to injury of the central 
nervous system. It has been suggested that apoE ε4 genotype is a 
risk factor for several neurological disorders. We investigated the 
correlation between the apoE genotype and radiological data 
in patients with cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL). 
T1-weighted, dual fast spin-echo, T2*-weighted gradient echo, 
and FLAIR magnetic resonance (MR) scans were obtained from 
36 CADASIL patients (21-59 years). The number of lacunar infarcts 
and microbleeds, and the presence of subcortical lacunar lesions 
were determined. The amount of white matter hyperintensities was 
assessed using semi-automated segmentation software. The relation 
between the radiological endophenotype of CADASIL and the apoE 
genotype was assessed using a Student t-test for unpaired data and 
Fisher’s exact test.
White matter hyperintensities, lacunar infarcts, microbleeds, and 
subcortical lacunar lesions were not found to be associated with the 
presence of an ε4 allele. 
The variability of structural MR lesions in CADASIL is independent 
of apoE genotype and other processes must underlie the variable 
natural history of the disease.
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Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is a hereditary small-artery vasculopathy 
caused by mutations in the NOTCH3 gene on chromosome 1919. The disease 
is clinically characterized by transient ischemic attacks, strokes, progressive 
subcortical dementia, migraine with aura, and mood disturbances. In general, 
death follows at an age of 55 to 65 years after a mean disease duration of 20 
years10. Magnetic resonance (MR) imaging fi ndings in CADASIL are present 
in symptomatic as well as asymptomatic mutation carriers, and consist of 
diffuse white matter hyperintensities (predominantly in the subcortical areas) 
and lacunar infarcts (in the centrum semiovale, thalamus, basal ganglia and 
pons). Recent MR studies have established microbleeds and subcortical 
lacunar lesions as additional radiological features of CADASIL78.
The phenotypic and radiological expression of CADASIL is variable, both 
between and within families. The mean age of onset is in the late thirties 
to early forties, with a wide range. Some individuals develop microbleeds 
and subcortical infarcts, while others do not. On MR imaging, the extent of 
white matter hyperintensities and lacunar infarction is variable. This suggests 
modulation by additional genetic and, or environmental factors. We 
postulated that the apolipoprotein E (apoE) gene is a candidate genetic 
modifi er in CADASIL.
ApoE is a glycoprotein that transports cholesterol and other lipids104. The 
apoE gene is located on chromosome 19 and has ε2, ε3, and ε4 alleles. It 
has been suggested that apoE dependent uptake of lipoproteins may play 
an important role in the development, maintenance, and response to injury 
of the central nervous system105. In recent studies, the apoE ε4 genotype has 
been consistently associated with severe neurodegeneration and seems to 
constitute a risk factor for several neurological disorders. The ε4 allele has turned 
out to be a major risk factor for Alzheimer’s disease, and lobar haemorrhages 
caused by amyloid angiopathy106. Adverse recovery after head trauma or 
other injury of the brain has also been linked to the ε4 allele105.
The aim of this study was to assess whether the radiological endophenotype 
of CADASIL is correlated to the apoE genotype. We hypothesised that ε4 allele 
carriers have more white matter hyperintensities, lacunar infarcts, microbleeds, 
and subcortical lacunar lesions than those with the ε2 and ε3 genotype.
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Materials and methods
Subjects
Members of 15 unrelated CADASIL families were asked to participate in a study 
on the clinical, radiological, and genetic aspects of CADASIL. In each family, 
the index patient had a proven NOTCH3 mutation. Patients were referred 
from various medical centres to our institution, which serves as a CADASIL 
referral centre. Patients were referred with the suspicion of CADASIL based 
on clinical signs and symptoms, a family history consistent with autosomal 
dominant inheritance, or suggestive MR changes. The diagnosis CADASIL was 
confi rmed by direct sequencing analysis of the NOTCH3 gene, according to 
previously described techniques22. 
A total of 36 DNA proven CADASIL mutation carriers were studied (19 women 
and 17 men, aged 21-59 years, mean 45 years). Symptomatic as well as 
asymptomatic mutation carriers were included. ApoE genotype in all mutation 
carriers was determined as described by Haan et al107. 
MR imaging
MR imaging was performed in all mutation carriers. All MR examinations were 
performed on a 1.5T MR system (Philips Medical systems, Best, The Netherlands). 
T1-weighted spin echo images (slice thickness 6 mm with a 0.6 mm interslice 
gap [6/0.6 mm], repetition time [TR]/echo time [TE] 600/20 ms, matrix 256x205, 
and a fi eld of view [FOV] 220x165 mm), dual T2-weighted fast spin echo (FSE) 
images (3.0/0.0 mm, TR/TE 3000/27/120 ms, matrix 256x205, FOV 220x220 mm), 
T2*-weighted gradient echo planar (EPI) sequence (6/0.6 mm, TR/TE 2598/48 
ms, matrix 256x192, FOV 220x198 mm, EPI factor 25), and fast fl uid-attenuated 
inversion recovery (FLAIR) images (3.0/0.0 mm, TR/TE 8000/100 ms, inversion 
time 2000 ms, matrix 256x192, FOV 220x176 mm) were obtained in the axial 
plane parallel to the inferior border of the genu and splenium of the corpus 
callosum.
White matter hyperintensities were defi ned as white matter areas with 
increased signal intensity as compared to the surrounding white matter on 
T2-, proton density weighted and FLAIR images (fi gure 1). The amount of white 
matter hyperintensities was assessed using semi-automated segmentation 
software (Department of Radiology, Division of Image Processing, Leiden 
University Medical Centre, Leiden, The Netherlands). Volume of white matter 
hyperintensities was corrected for total brain volume by dividing the individual 
volume of white matter hyperintensities by intracranial volume and expressed 
in %. 
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Lacunar infarcts were defi ned as parenchymal defects not extending to the 
cortical grey matter with a signal intensity following that of CSF on all pulse 
sequences, irrespective of size (fi gure 1). In an effort to differentiate lacunar 
infarcts from dilated perivascular spaces, areas that were isointense to CSF on 
all pulse sequence and located in the lower one-third of the corpus striatum, 
were excluded80,100. Subinsular perivascular spaces were differentiated from 
lacunar infarcts based on the description of Song et al: enlarged perivascular 
spaces have a featherlike confi guration, are isointense to CSF on T2- and T1-
weighted images, but do not have high signal on FLAIR images73. In an effort to 
differentiate perivascular spaces along the perforating arteries from lacunar 
infarcts a modifi cation of the descriptive criteria for perivascular spaces 
as used by Bokura et al was applied: all lesions with a transverse diameter 
smaller or equal to 2 mm or with a tubular appearance following the course 
of perforating arteries were most likely to represent perivascular spaces and 
were excluded as well81. 
Microbleeds were defi ned as focal areas of signal loss on T2-weighted FSE 
images that increased in size on the T2*-weighted gradient echo pulse 
sequence (“blooming effect”)76. In this way, microbleeds were differentiated 
from areas of signal loss based on vascular fl ow voids. Areas of symmetric 
hypointensity of the globus pallidus likely to represent calcifi cation or 
nonhemorrhagic iron deposits were excluded (fi gure 1)78.
Subcortical lacunar lesions were defi ned as linearly arranged groups of 
rounded, circumscribed lesions just below the cortex, at the grey-white matter 
junction with a signal intensity that was identical to that of CSF on all pulse 
sequences (fi gure 1)92. One experienced neuroradiologist (MAvB) assessed the 
number of lacunar infarcts and microbleeds, and the presence of subcortical 
lacunar lesions. He was blinded to the apoE status.
Only cognitively capable subjects were included into this study to ensure 
acquisition of informed consent. Informed consent was obtained from all 
subjects. The medical ethics committee of our institution approved the study 
protocol. 
Statistical analysis
As subdivision by genotype would reduce the group size and thereby decrease 
the statistical power too much, we obtained descriptive statistics for the mean 
volume of white matter hyperintensities, number of lacunar infarcts, number of 
microbleeds and presence of subcortical lacunar lesions. Differences in age, 
white matter hyperintensities, lacunar infarcts, and microbleeds between ε4 
allele carriers and non-ε4 allele carriers were then investigated with a Student 
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t-test for unpaired data. Differences in subcortical lacunar lesions were tested 
using the Fisher’s exact test. A P-value of P<0.05 was considered signifi cant. 
The statistical package SPSS-10 (SPSS, Inc) was used for data analysis.
Results
Of the 36 mutation carriers studied, 29 had neurological symptoms, ranging 
from one transient ischemic attack to multiple strokes and cognitive defi cits. 
Eight were ε4 allele carriers and 28 had no ε4 allele. The complete distribution 
of apoE genotype was as follows: ε2/ε3 n=1(3%); ε3/ε3 n=26 (72%); ε3/ε4 n=8 
(22%); ε2/ε2 n=1(3%); ε4/ε4 n=0. 
Results of the MR imaging analysis are shown in table 1. No signifi cant difference 
was found between the ε4 allele carriers and the non-ε4 allele carriers in age 
(P=0.46) volume of white matter hyperintensities (P=0.84), number of infarcts 
(P=0.27), number of microbleeds (P=0.58), or subcortical lacunar lesions 
(P=0.66). 
All 
(n=36)
ε4 allele 
carriers 
(n=8)
Non-ε4 
allele arriers
(n=28)
95% confi dence
interval of the 
difference
Age in years* 44.9 (11) 47.5 (7.9) 44.2 (11.7) -4.2–10.9
Percentage white 
matter hyperintensities* 
8.2 (5.9) 8.6 (6.4) 8.1 (5.9) -5.1–6.0
Number lacunar infarcts* 8.8 (12.6) 13.1 (14.7) 7.5 (11.9) -7.1–18.3
Number of microbleeds* 2.4 (6.5) 1.3 (2.6) 2.7 (7.3) -4.8–1.9
Number of persons with 
subcortical lacunar infarcts**
18 (50%) 4 (50%) 14 (50%)
Table 1 MR imaging fi ndings in apoE genotype subgroups. There is no signifi cant difference 
in MR imaging fi ndings between ε4 allele carriers and non-ε4 allele carriers
Data are given as *mean (SD) and **frequency (percent)
Discussion
There are several studies that address the issue of the considerable variability 
in the rate of progression and survival between individual CADASIL patients. 
Evidence suggests that male patients have a shorter survival than female 
patients10,108. One study has systematically compared the infl uence of 
different NOTCH3 mutations on the disease phenotype and found no 
obvious effect of single mutations on the volume of lesions seen on brain MR 
imaging109. Other studies focused on the infl uence of vascular comorbidity 
including hypertension, smoking, diabetes mellitus and hypercholesterolemia 
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on phenotype and the development of white matter hyperinstensities and 
microbleeds76,110. No strong genotype-phenotype relationships in CADASIL 
was found.
 
c) d) 
a) b) 
Figure 1 Axial FLAIR (a-c) and T2*-weighted gradient (d) MR images of CADASIL patients. 
Complete MR spectrum of CADASIL: confl uent hyperintensities (a-c), lacunar infarcts (arrow 
in a), subcortical lacunar lesions (arrow in b) and microbleeds (arrow in d). 
In sporadic amyloid angiopathy as well as in Alzheimer’s disease, the apoE 
genotype is a strong predictor of the clinical expression of disease and the 
development of cerebral structural (including vascular) lesions. There are 
indications that in Alzheimer’s disease concomitant vascular lesions, such 
as infarcts, white matter hyperintensities, and haemorrhagic infarcts are 
associated with the ε4 allele106. In our CADASIL study population, the ε4 allele 
frequency was almost the same (22%) as in the general Dutch population 
(30%), offering the possibility to compare ε4 carriers with non-carriers111. In 
our study the apoE genotype was not signifi cantly associated with structural 
changes seen on MR imaging, suggesting that in CADASIL, structural lesions 
caused by vascular changes are independent of apoE ε4 genotype. It is 
possible that the vascular effect of apoE genotype observed in other diseases, 
is dependent on amyloid angiopathy.
Chapter 7
84
Our results extend those of an earlier study of Singhal et al, that found no 
correlation of the apoE genotype with white matter hyperintensities on 
MR imaging110. In addition to that observation we also observed a lack of 
correlation between apoE genotype and occurrence of the other radiological 
hallmarks of CADASIL: lacunar infarcts, microbleeds, and subcortical lacunar 
infarcts. In contrast to that study, we used a more extensive MR protocol as 
objective measure of disease severity. We believe that clinical parameters, 
contrary to structural MR lesions, are a less valid measure of the burden of the 
disease because of superimposed external factors. Furthermore, not all brain 
lesions produce clinical symptoms. 
A potential limitation of our study may be that only patients who were able 
to understand the informed consent were included and therefore the most 
severely affected patients might have been excluded. However, at this end 
stage of the disease the phenotypic as well as the radiological expression 
of CADASIL does not differ as much as at a younger age and therefore we 
believe that our results are not infl uenced by excluding these patients.
In conclusion, our population included 36 CADASIL mutation carriers. By using 
a very rigorous objective measure for the disease burden, namely the MR 
imaging-endophenotype, we may conclude that the variability of structural 
MR lesions in CADASIL patients are independent of apoE ε4 genotype and 
that other processes such as environmental and other genetic factors must 
underlie the variable natural history of the disease. 
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Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL) is a hereditary small-vessel 
disease caused by mutations in the NOTCH3 gene on chromosome 
19. On magnetic resonance (MR) imaging, subcortical white matter 
hyperintensities and lacunar infarcts are visualised. It is unknown 
whether a decrease in cerebral blood fl ow or cerebrovascular 
reactivity is primarily responsible for the development of white matter 
hyperintensities and lacunar infarcts.
We used phase contrast MR imaging in 40 NOTCH3 mutation carriers 
(mean age 45 ±10 years) and 22 non-mutated family members (mean 
age 39 ±12 years), to assess baseline total cerebral blood fl ow (TCBF) 
and cerebrovascular reactivity after acetazolamide. 
Mean baseline TCBF was signifi cantly decreased in NOTCH3 mutation 
carriers. In young subjects, baseline TCBF was signifi cantly lower than 
in non-mutation carriers (mean difference 124 ml/min). Furthermore, 
baseline TCBF did not differ signifi cantly between mutation carriers with 
minimal and mutation carriers with moderate or severe white matter 
hyperintensities. No signifi cant difference in mean cerebrovascular 
reactivity was found between mutation carriers and non-mutation 
carriers.
This study suggests that a decrease in baseline TCBF in NOTCH3 
mutation carriers precedes the development of white matter 
hyperintensities.
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Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is a hereditary small-artery disease, clinically 
characterised by transient ischemic attacks, strokes, progressive subcortical 
dementia, migraine with aura, and mood disturbances8,10,11. Mutations in the 
NOTCH3 gene are associated with CADASIL19. On pathological examination, 
characteristic depositions of granular osmiophilic material within the media 
of the small and medium sized leptomeningeal and long perforating arteries 
of the brain are found. This vasculopathy results in destruction of vascular 
smooth muscle cells and fi brous thickening of the arterial wall7,26. Magnetic 
resonance (MR) imaging reveals symmetrical white matter hyperintensities 
(WMHs), often associated with small lacunar infarcts in the white matter and 
basal ganglia39-41.
Cerebrovascular reactivity refl ects the compensatory dilatory capacity of 
cerebral arterioles to a stimulus such as carbon dioxide or acetazolamide. In 
elderly individuals impaired cerebrovascular reactivity is associated with WMHs 
and lacunar infarcts27-29. In patients with CADASIL, alterations in cerebral blood 
fl ow and cerebrovascular reactivity have also been shown, with a signifi cant 
reduction in baseline cerebral blood fl ow and cerebrovascular reactivity in 
areas of WMHs30-33.
The aim of the present study was to further explore the correlation of fl ow 
disturbance and WMHs. We hypothesised that fl ow disturbance is the primary 
event that gives rise to the development of WMHs. To address this issue, we 
assessed baseline total cerebral blood fl ow (TCBF) and cerebrovascular 
reactivity using phase contrast MR imaging in CADASIL patients with minimal 
WMHs, in CADASIL patients with moderate or severe WMHs, and in non-
mutated family members.
Materials and methods
Subjects
Sixty-three members of 15 CADASIL families participating in an ongoing study 
of CADASIL, agreed to undergo MR imaging. NOTCH3 mutation screening 
was performed for all subjects by direct sequencing analysis22. Family 
members who proved not to have a NOTCH3 mutation served as a control 
group. Participants were considered symptomatic when they had a history 
of neurologic defi cits or cognitive decline. In addition to the standard MR 
imaging protocol, 38 participants gave permission for the administration of 
acetazolamide. The institutional medical ethical committee approved the 
study. 
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MR imaging
All imaging was performed on a MR system operating at a fi eld-strength of 
1.5 Tesla (Philips Medical Systems, Best, The Netherlands). Conventional T1-
weighted spin echo images (slice thickness 6 mm with a 0.6 mm interslice gap, 
TR/TE 600/20 ms, matrix 256 x 205, and a fi eld of view (FOV) 220 x 165 mm), 
dual T2-weighted fast spin echo (FSE) images (slice thickness 3 mm without 
interslice gap, TR/TE 3000/27/120 ms, matrix 256 x 205, FOV 220 x 220 mm), 
and fast fl uid-attenuated inversion recovery (FLAIR) images (3.0/0.0 mm, TR/TE 
8000/100 ms, inversion time 2000 ms, matrix 256 x 192, FOV 220 x 176 mm) were 
obtained. All images were performed in the axial plane parallel to the inferior 
border of the genu and splenium of the corpus callosum. A gradient echo 
phase contrast technique (TR/TE 16/9 ms; fl ip angle 7.5°; 5 mm slice thickness; 
FOV 250 x 188 mm; matrix 256 x 154) with a velocity encoding of 100 cm/s 
was used for non-triggered fl ow measurements112. The scan plane was chosen 
perpendicular to the basilar artery and both internal carotid arteries. Cerebral 
blood fl ow was measured ten minutes before the administration of 14 mg/kg 
acetazolamide intravenously and repeated at 5, 10, 15, and 20 minutes after 
the administration of acetazolamide. The same position of the scan plane was 
used for repeated fl ow measurements. Blood pressure, peripheral saturation, 
and heart rate were continuously monitored.
For cerebral blood fl ow assessment, images were analysed using the software 
package FLOW®93,113. A region of interest was manually drawn around the 
basilar artery and the left and right internal carotid artery in the phase image 
by one observer (RvdB). The fl ow volume was calculated by integrating the 
fl ow velocity values within the contour multiplied by the area. Flow in the 
basilar artery and the left and right internal carotid artery were added and 
considered to represent TCBF in ml/min114. The baseline TCBF and maximum 
TCBF were respectively defi ned TCBF before and the maximum TCBF obtained 
after the administration of acetazolamide. Cerebrovascular reactivity was 
defi ned as: cerebrovascular reactivity = (maximum TCBF - baseline TCBF) / 
baseline TCBF x 100%. 
WMHs and lacunar infarcts rating
WMHs were defi ned as white matter areas with increased signal intensity 
on intermediate, T2-, and FLAIR weighted images. WMHs volume (in ml) 
measurements were performed on FSE dual images by one observer, using 
a locally developed semi-automated segmentation software that combines 
knowledge-based fuzzy clustering and region growing techniques. The 
software computes an additional T2/proton density angle image in order 
to distinguish the lesions from cerebrospinal fl uid. Volume of WMHs was 
corrected for total brain volume by dividing the individual volume of WMHs by 
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intracranial volume and expressed in percentage. The whole post processing 
procedure yielded an intraclass correlation coeffi cient of >0.99 (95% CI: 0.96-
1.0) in an analysis of data sets from 10 patients examined twice by the same 
observer who performed the automated segmentation.
In addition, the number of lacunar infarcts, defi ned as parenchymal defects 
not extending to the cortical grey matter with a signal intensity following that 
of cerebrospinal fl uid on all pulse sequences, irrespective of size, were counted 
on hardcopies by an experienced neuroradiologist. In the basal ganglia, areas 
that were isointense to cerebrospinal fl uid on all pulse sequence and located 
in the lower one-third of the corpus striatum were excluded in an effort to 
differentiate lacunar infarcts from normal dilated perivascular spaces80,100.
Statistical analysis
Differences between NOTCH3 mutation carriers and non-mutated individuals 
in volume of WMHs, number of lacunar infarcts and fl ow parameters, were 
performed with ANOVA. Increase of TCBF after acetazolamide was analysed 
with paired t-test and the effect of age on volume of WMHs and baseline TCBF 
with linear regression analysis. In a second phase of the analysis the mutation 
carriers were separated into groups with minimal volume of WMHs and with 
moderate or severe volume of WMHs, to assess the nature of the correlation 
between WMHs and fl ow changes. ANOVA was performed with age and sex 
as covariates. A P-value of P<0.05 was considered signifi cant. The statistical 
package SPSS-10 (SPSS, Inc) was used for data analysis.
Table 1 Baseline characteristics of the CADASIL population
Results
Subjects
Of 63 CADASIL family members, 41 subjects had a mutation in the NOTCH3 
gene and 22 did not. One individual had an incomplete MR imaging 
examination due to claustrophobia and was therefore excluded from the 
analysis. The mean age of the remaining 40 NOTCH3 mutation carriers was 
NOTCH3 non-mutation 
carriers (n=22)
NOTCH3 mutation 
carriers (n=40)
Mean age, yr (SD) 39 (±12) 45 (±10)
Male, n (%) 10 (45) 19 (48)
Hypertension, n (%) 5 (23) 3 (8)
Symptomatic/
asymtomatic, n
0/22 33/7
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45 years ±10 years. Thirty-three patients of this group were symptomatic, with 
symptoms ranging from one transient ischemic attacks to multiple strokes 
and cognitive decline. Seven mutation carriers were asymptomatic. The 22 
non-mutation carriers had a mean age of 39 years ±12 years, and were all 
asymptomatic (table 1). Twenty-three mutation carriers (six with minimal and 
17 with moderate and severe WMHs) and 15 non-mutated carriers consented 
to administration of acetazolamide. 
Table 2 Differences between NOTCH3 non-mutation and NOTCH3 mutation carriers in WMHs 
volume, number of lacunar infarcts, and fl ow parameters.
NOTCH3 non-mutation 
carriers (n=22)
NOTCH3 mutation 
carriers (n=40)
P-value
Mean WMH volume, % 
(range)
0.01 (0-0.08) 5.2 (0-15) < 0.001
Mean no. of lacunar infarcts 
(range)
0.5 (0-10) 15 (0-60) < 0.001
Mean bTCBF, ml/min (±SD) 721 (±156) 566 (±133) < 0.001
Mean CVR, % (±SD)* 69 (±21) 62 (±18) 0.26
P values by analysis of variance. For mean CVR, n=38 (seem methods). WMH=white 
matter hyperintensities; bTCBF baseline total cerebral blood fl ow; CVR=cerebrovascular 
reactivty
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Figure 1. Graph shows white matter hyperintensities (WMH) volume according to age in 
NOTCH3 non-mutation and mutation carriers. WMH increase with age in NOTCH3 mutation 
carriers but not in NOTCH3 non-mutation carriers.
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NOTCH3 non-
mutation carriers
NOTCH3 mutation carriers
minimal WMH moderate/ 
severe WMH
P-value
n 22 8 32
Mean age, yr (±SD) 39 (±12) 29 (±9) 49 (±6) < 0.001
Mean WMH volume % (range) 0.01 (0-0.08) 0.5 (0.02-1.3) 6.5 (1.7-15) < 0.001
Mean bTCBF, ml/min (±SD)
   Uncorrected 721 (±136) 682 (±136) 537 (±136) < 0.001
   Corrected for age 705 (±136) 624 (±150) 562 (±147) 0.003
   Corrected for age and sex 704 (±136) 620 (±158) 563 (±147) 0.004
Table 3. Flow parameters in NOTCH3 non-mutation carriers and the NOTCH3 mutation 
carriers with minimal WMH and moderate and severe WMH
P values by analysis of variance. WMH=white matter hyperintensities; bTCBF=baseline 
total cerebral blood fl ow
Comparison between NOTCH3 mutation carriers and non-mutation carriers. 
The total volume of WMHs, number of lacunar infarcts, and fl ow parameters 
are given in table 2. The mutation carriers had a signifi cantly higher volume of 
WMHs and a higher number of lacunar infarcts, whereas baseline TCBF was 
signifi cantly lower. In both groups, the average TCBF increased signifi cantly 
after the administration of acetazolamide (P<0.001). Because the increase in 
TCBF on administration of acetazolamide was proportional to baseline TCBF, 
no signifi cant difference in cerebrovascular reactivity was found. 
The changes in volume of WMHs according to age are graphically represented 
in fi gure 1. This fi gure shows that there is an increase in volume of WMHs in 
mutation carriers with age; volume of WMHs in non-mutated carriers did not 
increase. 
In fi gure 2, changes in baseline TCBF versus age are demonstrated. As shown 
by the parallel regression lines through the NOTCH3 mutation carriers and the 
NOTCH3 non-mutation carriers the TCBF was lower at any age in the NOTCH3 
mutation carriers (mean difference 124 ml/min, P=0.001). 
Comparison between NOTCH3 mutation carriers with minimal and moderate/
severe WMHs. 
Figure 1 shows that there were eight NOTCH3 mutation carriers with minimal 
and 32 NOTCH3 mutation carriers with moderate or severe WMHs. The cut 
off value of volume of WMHs was 1.5%. To study the correlation between low 
TCBF and WMHs in patients with a NOTCH3 mutation, we used this cut off 
value to separate the NOTCH3 mutation carriers in those with minimal WMHs 
and those with moderate or severe WMHs (table 3). The highest baseline TCBF 
was present in the NOTCH3 non-mutation carriers, followed by the NOTCH3 
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Discussion
In CADASIL patients two types of lesions affecting small cerebral arteries are 
observed that might affect cerebral haemodynamics. First, the arteriolar 
lumen is narrowed as a consequence of fi brous thickening of the arterial wall. 
This phenomenon presumably reduces baseline blood fl ow. Second, vascular 
smooth muscle cells are destroyed, which might impair the vascular dilatory 
response to hypoxia30,32. In this study, we found a decrease in baseline TCBF in 
NOTCH3 mutation carriers as compared with NOTCH3 non-mutation carriers, 
whereas the capacity of the arterial wall to dilate, measured by acetazolamide 
response, appeared normal in NOTCH3 mutation carriers. These observations 
suggest that narrowing of the arterial lumen has a more profound effect on 
cerebral haemodynamics in CADASIL patients than dysfunction of vascular 
smooth muscle cells.
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Figure 2. Baseline total cerebral blood fl ow (bTCBF) in NOTCH3 mutation and non-mutation 
carriers. bTCBF is signifi cantly lower in NOTCH3 mutation carriers compared with NOTCH3 
non-mutation carriers (mean difference 124 ml/min).
mutation carriers with minimal and NOTCH3 mutation carriers with moderate 
or severe WMHs (ANOVA, P<0.001). After adjustment for age and adjustment 
for age and sex, the difference in corrected baseline TCBF values remained 
signifi cant. Post hoc analysis showed that the difference in baseline TCBF 
between NOTCH3 mutation carriers with and without moderate or severe 
WMHs was not signifi cant. 
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An alternative explanation for the observed reduced baseline TCBF in 
NOTCH3 mutation carriers could also be raised. NOTCH3 encodes for a 
transmembrane protein with a receptor and cell signal transduction function. 
Besides to NOTCH3, there are three other known mammalian NOTCH 
proteins115. Evidence from several of studies has indicated a role for Notch 
signalling during vascular development116. For example, an activated form of 
NOTCH4 in the embryonic vasculature causes abnormal vessel structure and 
patterning117. Possibly, mutations in NOTCH3 may also lead to an abnormal 
development of the cerebral vasculature in CADASIL. The observation that 
fl ow abnormalities were present in all age groups in this study could thus be 
explained by such an innate structural abnormality of cerebral blood vessels, 
and not necessarily acquired structural abnormalities.
Using MR bolus tracking and acetazolamide in CADASIL patients, Chabriat 
et al found a reduction in both baseline perfusion and cerebrovascular 
reactivity within WMHs32. Similarly, Mellies et al observed a reduction in grey 
matter perfusion that correlated with the amount of WMHs, using SPECT31. 
These observations, however, have not made it clear whether structural 
brain changes are secondary to impaired fl ow, or whether impaired fl ow is a 
consequence of brain damage.
Several observations in our study provide insight into the nature of the 
correlation between WMHs and lacunar infarcts on the one hand, and 
cerebral fl ow disturbance on the other. In this study, we assessed TCBF based 
on phase contrast MR imaging. This method provides robust quantitative data 
on the total amount of blood fl owing to the brain114,118. Using phase contrast 
MR imaging we found a signifi cantly diminished baseline TCBF at any age, 
even in young NOTCH3 mutation carriers with minimal structural lesions (fi gure 
2). It is unlikely that the cerebral blood fl ow to the brain is signifi cantly reduced 
by a fl ow reduction in these small lesions, which only represent a very small 
percentage of the brain volume. A more realistic explanation is that the 
observed TCBF reduction in these patients is the result of more widespread 
fl ow impairment, which not just affects the areas of WMHs and lacunar infarcts. 
Furthermore, in all CADASIL patients with minimal WMHs and minimal lacunar 
infarcts, irrespective of age, baseline TCBF was observed to be abnormal. 
Both observations suggest that a reduction in baseline fl ow precedes, and is 
responsible for, the occurrence of WMHs and lacunar infarcts in CADASIL. 
In this study we did not fi nd evidence for a decreased  cerebrovascular 
reactivity in CADASIL patients. This fi nding differs from observations in other 
studies. Several explanations for this seeming contradiction can be put forward. 
First, the CADASIL patients who participated in our study were younger then 
those in the other studies. A reduced cerebrovascular reactivity might be more 
pronounced in an older patient population. Second, in our study a different 
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technique for fl ow quantifi cation was used as compared with previous 
studies. In these other studies, single-photon emission computed tomography, 
positron emission tomography, MR bolus tracking, and transcranial Doppler 
ultrasound were used to estimate changes in cerebral blood fl ow30,31,32,119. 
With the exception of transcranial Doppler, these techniques detect fl ow 
changes in brain parenchyma, not changes in the supplying vessels of the 
brain. In a recent article, poor correlations were found between estimates 
of cerebrovascular reactivity based on MR bolus tracking and those based 
on phase contrast MR imaging, which was attributed to the two methods 
refl ecting different aspects of the cerebrovascular reactivity120. However, both 
transcranial Doppler and phase contrast MR imaging enable the measurement 
of blood fl ow velocity in extraparenchymal vessels. Still, others showed poor 
correlation between fl ow data resulting from these two methods, which was 
attributed to a lack of reproducibility of transcranial Doppler measurements 
because of operator dependency121. In this study we decided to use phase 
contrast MR imaging as this technique has the advantage of being operator 
independent and involving straightforward fl ow volume quantifi cation as 
demonstrated by Bakker and Spilt et al112,120,122. In addition, phase contrast MR 
imaging has the advantage of providing during one examination both fl ow 
data and morphological data which is not possible with other techniques. 
In conclusion, our fi ndings suggest that fl ow impairment gives rise to the 
development of WMHs and lacunar infarcts in CADASIL patients. Furthermore, 
in CADASIL patients with minor white matter hyperintensities the TCBF is 
reduced in rest, whereas the cerebral vascular dilatory capacity is preserved. 
This novel observation is relevant, because it may imply that by increasing 
the cerebral blood fl ow through a challenge of the remaining vasodilatory 
capacity, vasodilatory agents might limit the development of WMHs and 
lacunar infarcts in CADASIL patients. Further studies are needed to determine 
the effi cacy of pharmacological improvement of cerebral blood fl ow in 
CADASIL patients. 
N
I
N
E
Summary and conclusions
97
Summary and conlusions
Summary and conclusions
Magnetic resonance (MR) imaging plays an important role in the diagnostic 
work-up of CADASIL patients. This thesis describes the typical appearance of 
MR abnormalities in CADASIL patients, the natural history of these abnormalities, 
and the differences of these lesions as compared to the lesions that occur in 
multiple sclerosis (MS). Also included are the results of a study on the infl uence 
of apolipoprotein E (apoE) genotype and a study of cerebral blood fl ow on 
the development of MR abnormalities. 
In chapter 1 a short introduction is given on the aetiology and clinical 
appearance of CADASIL, the initial radiological descriptions of cerebral 
lesions, and the role of imaging in the diagnostic work-up of these patients. 
Furthermore the goal and outline of this thesis are portrayed.
In chapter 2 we assessed whether microbleeds are present in CADASIL and, 
if so, whether they are associated with other patient characteristics. Several 
studies have shown that microbleeds are associated with the presence of 
intracerebral haemorrhage. Although there are some descriptions on the 
occurrence of intracerebral haemorrhage in patients with CADASIL, the 
prevalence of haemorrhages in CADASIL patients was unknown at the start of 
this study. By using a T2* gradient-echo technique, detection of haemosiderin 
deposits refl ecting remnants of intracerebral microbleeds is possible. In this 
study we found that 31% of symptomatic CADASIL patients had microbleeds 
on MR imaging, predominantly in the thalamus (fi gure 1). This suggests that 
CADASIL patients might be at risk for developing intracerebral haemorrhage.
In chapter 3 we describe a new radiological fi nding in CADASIL patients, the 
so called subcortical lacunar lesions (SLLs). SLLs are linearly arranged groups 
of rounded, circumscribed lesions just below the cortex, at the grey white 
matter junction with a signal intensity that is identical to that of CSF on all pulse 
sequences. These lesions are best seen on thin sections (3mm) fl uid-attenuated 
inversion-recovery (FLAIR) images (fi gure 2a,b). SLLs were found in 59% of 
CADASIL patients, and when present, SLLs invariably occurred in the anterior 
temporal lobe, always in combination with white matter hyperintensities 
(WMHs). Because none of the control subjects showed SLLs, we believe that 
SLLs are highly characteristic for CADASIL and detection of SLLs might help in 
establishing de diagnosis of CADASIL. Histological examination revealed that 
the lesions are caused by a distention of the perivascular space of perforating 
arteries (fi gure 2c).
In chapter 4 we describe the natural history of the various brain lesions that 
can be observed in CADASIL patients. These lesions include not only WMHs 
and lacunar infarcts but also the recently reported microbleeds and SLLs. The 
results of this study showed that these lesions develop in a predictable way 
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during the course of the disease. Hyperintensities were present in all CADASIL 
patients, increasing with age and with a predilection for the temporal and 
frontal lobe (fi gure 3). In young CADASIL patients (20-30 years), hyperintensities 
in the anterior temporal lobe, in one patient in combination with SLLs, are the 
only abnormalities seen on MR imaging. The development of lacunar infarcts 
starts in the fourth decade. Microbleeds occurred during the fi fth and sixth 
decade. In patients older than 50 years all four abnormalities were frequently 
observed. Knowledge of these age dependent MR patterns should help to 
make the diagnosis of CADASIL.
a) b) c) 
 
Figure 1 Axial T2*-weighted gradient echo planar images show numerous microbleeds, 
located in the thalamus, cerebellum as well as deep and subcortical white matter 
(arrows).
In chapter 5 we describe the results of a study in which we compared the 
neuropsychological, clinical, and neuroradiological features of CADASIL 
patients and controls between 21 and  35 years of age. The main results were 
that there was no quantifi able physical or cognitive impairment in young 
CADASIL patients. Disease expression was only confi ned to migraine and, 
less frequently, TIA and (minor) stroke. Radiologically, a characteristic MR 
lesion pattern was present in all CADASIL patients. WMHs, sometimes subtle, 
were present in the frontal lobes and periventricular frontal caps, but most 
importantly, fi rst appeared in the anterior temporal lobe (fi gure 3).
In chapter 6 we compared the radiological appearance of CADASIL to that 
of multiple sclerosis (MS), a disease with clinical and radiological similarities to 
CADASIL. CADASIL patients showed signifi cantly more SLLs and hyperintensities 
in the anterior temporal lobe and the external capsule compared with MS. 
Although in general practice the prevalence of MS is higher than of CADASIL, 
the hyperintensities in the anterior temporal lobe especially in combination 
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with one of the other CADASIL MR hallmarks should lead to the diagnosis of 
CADASIL. MR imaging permits discriminating between CADASIL and MS, even 
at a young age, so that misdiagnosis can be avoided.
b) a) 
c) 
 
Figure 2 Axial FLAIR MR images show SLLs affecting the anterior part of the temporal lobe (a) 
and the subinsular region (b). Photomicrograph (c) shows detail of two vessels. The lower 
part of the vessel on the left shows characteristic thickening of the arterial wall; both vessels 
have a distended perivascular space (arrows) and spongiosis of the adjacent parenchyma 
(arrowhead) (Haematoxylin-eosin stain; original magnifi cation, x100.).
In chapter 7 the infl uence of apoE genotype on the development of structural 
brain lesions of CADASIL is studied. The apoE genotype, a well known genetic 
risk factor for Alzheimer’s disease and sporadic cerebral amyloid angiopathy, 
does not infl uence the amount of structural cerebral changes as seen on MR 
imaging in CADASIL patients. Therefore other genetic or non-genetic factors 
probably underlie the variable natural history of the disease.
Chapter 8 deals with the question whether a decrease in cerebral blood fl ow 
or cerebrovascular reactivity is primarily responsible for the development of 
WMHs and lacunar infarcts. To address this issue, phase contrast MR imaging 
was used to assess baseline total cerebral blood fl ow and cerebrovascular 
reactivity after acetazolamide. The response on acetazolamide was not 
decreased relative to the baseline total cerebral blood fl ow. However, the 
mean baseline total cerebral blood fl ow was signifi cantly decreased in 
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patients with CADASIL. These fi ndings suggest that vascular stenosis plays a 
larger role in the development WMHs and lacunar infarcts in CADASIL patients, 
than diminished vascular reactivity. 
a) b) c) 
d) e) f) 
Figure 3 FLAIR MR images of three mutation carriers aged 26, 46 and 53 years. Axial slices 
through the level of the temporal lobes and basal ganglia showing the development of 
WMHs in the temporal lobe and external and internal capsule. 
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Sinds de zeventiger jaren van de vorige eeuw zijn families beschreven met 
dominant overervende herseninfarcten, dementie en witte stofafwijkingen 
zichtbaar op CT- en MRI-onderzoek. De aandoening werd met verschillende 
namen aangeduid waaronder onder andere “hereditaire multi-infarct 
dementie en chronische familiaire vasculaire encephalopathie”. In 1993 werd 
het acroniem CADASIL (cerebrale autosomaal dominante arteriopathie met 
subcorticale infarcten en leukoencephalopathie) geïntroduceerd en in 1996 
werd een gemuteerd gen, het NOTCH3 gen op chromosoom 19, ontdekt bij 
CADASIL-patiënten.
De voornaamste kenmerken van deze dominant overervende aandoening 
zijn recidiverende transient ischemic attacks (TIA’s; aanvallen van kortdurende 
neurologische uitval), herseninfarcten en een progressieve vasculaire 
dementie. Tevens zijn migraine met aura, stemmingstoornissen en in mindere 
mate epilepsie beschreven. Patiënten met CADASIL overlijden over het 
algemeen op een leeftijd van 55 tot 65 jaar, na een ziekteduur van 10 à 20 
jaar. 
CADASIL berust op een non-atherosclerotische, non-amyloidotische 
angiopathie met typische granulaire deposities in de media van de kleine 
cerebrale arteriën. Ook zijn deze vaatwandveranderingen aangetoond 
elders in het lichaam, bijvoorbeeld in de huidarteriolen. Echter hier geven 
deze veranderingen niet zoveel schade als in de hersenen.
MRI-onderzoek van de hersenen bij CADASIL-patiënten toont witte 
stofafwijkingen en lacunaire infarcten. De meeste witte stofafwijkingen 
bevinden zich periventriculair en frontotemporaal. Opvallend is dat de witte 
stofafwijkingen ook gevonden kunnen worden bij familieleden van CADASIL-
patiënten die nog geen klinische verschijnselen van de ziekte hebben. 
MRI speelt een belangrijke rol in de diagnostische work-up van CADASIL-
patiënten. 
Het proefschrift bestaat uit zeven studies die zich achtereenvolgens richten 
op de volgende vragen:
1) Hebben CADASIL-patiënten een verhoogd risico op hersenbloedingen?
2) Is er een relatie tussen de hoeveelheid microbloedingen en de ernst van 
de ziekte?
3) Wat is de prevalentie en distributie van zogenaamde subcorticale 
lacunaire laesies?
4) Welke MRI-afwijkingen worden aangetroffen bij CADASIL-patiënten en wat is 
de prevalentie van deze afwijkingen bij verschillende leeftijdcategorieën?
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5) Wat zijn de klinische, neuropsychologische en radiologische bevindingen 
bij CADASIL-patiënten jonger dan 35 jaar?
6) Is het mogelijk om CADASIL en multiple sclerosis radiologisch van elkaar 
te onderscheiden?
7) Wat is de invloed van het apolipoproteine E (apoE) genotype op het 
ontwikkelen van radiologische afwijkingen bij CADASIL?
8) Is primair een afname in cerebrale bloedstroom of een afname in de 
cerebrovasculaire reactiviteit verantwoordelijk voor de ontwikkeling van 
witte stofafwijkingen en lacunaire infarcten?
In hoofdstuk 1 wordt een korte beschrijving gegeven van het ziektebeeld 
CADASIL. Vervolgens worden doel en opzet van dit proefschrift beschreven.
In hoofdstuk 2 wordt onderzocht of cerebrale microbloedingen 
voorkomen bij CADASIL patiënten en of ze geassocieerd zijn met andere 
patiëntenkarakteristieken. Met behulp van een speciale MRI-techniek 
om haemosiderine te detecteren, de zogenaamde T2* gradient-echo 
sequentie, is in deze studie aangetoond dat 31% van de CADASIL-
patiënten microbloedingen heeft, met name in de thalamus. Cerebrale 
microbloedingen worden in andere studies geassocieerd met een verhoogd 
risico op hersenbloedingen, derhalve dient men ook bij CADASIL-patiënten 
bedacht te zijn op dit mogelijk verhoogd risico op hersenbloedingen. Er is 
geen duidelijke relatie gevonden tussen de hoeveelheid microbloedingen en 
de hevigheid van de ziekte.
Hoofdstuk 3 beschrijft een nieuwe radiologische bevinding bij CADASIL-
patiënten, de zogenaamde subcorticale lacunaire laesie. Subcorticale 
lacunaire laesies zijn kleine ronde laesies, lineair gerangschikt op de grens van 
de grijze en witte stof, met dezelfde signaalintensiteit als liquor cerebrospinalis. 
Deze laesies zijn het beste te zien op een fl uid-attenuated inversion recovery 
sequentie (FLAIR) met dunne coupes. In 59% van de CADASIL-patiënten worden 
subcorticale lacunaire laesies gevonden. Subcorticale lacunaire laesies 
bevinden zich altijd in de anterieure temporaal kwab en altijd aangrenzend 
aan afwijkende witte stof. Histologisch blijken subcorticale lacunaire laesies te 
berusten op verwijde perivasculaire ruimtes. Deze afwijking wordt niet gezien 
op MRI-onderzoeken van controlegroepen en daarom kan de aanwezigheid 
van subcorticale lacunaire laesies een specifi eke diagnostische aanwijzing 
zijn voor CADASIL. 
In hoofdstuk 4 worden het patroon en het natuurlijke beloop van alle MRI-
afwijkingen die bij CADASIL zijn beschreven, namelijk witte stofafwijkingen, 
lacunaire infarcten, microbloedingen en subcorticale lacunaire laesies, 
onderzocht. Deze MRI-afwijkingen ontwikkelen zich volgens een vast 
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patroon. Bij jonge CADASIL-patiënten (tussen de 20 en 30 jaar) staan witte 
stofafwijkingen in de anterieure temporaalkwab en subcorticale lacunaire 
laesies op de voorgrond. Na de leeftijd van 30 jaar komen lacunaire 
infarcten voor bij de meerderheid van de CADASIL-patiënten en boven de 
40 jaar zijn microbloedingen te zien. Bij patiënten ouder dan 50 jaar komen 
in de meerderheid van de gevallen deze afwijkingen gelijktijdig voor. De 
uitgebreidheid van de witte stofafwijkingen neemt toe met de leeftijd. Kennis 
van deze leeftijdgerelateerde MRI-afwijkingen is met name belangrijk voor de 
diagnostiek van CADASIL.
In hoofdstuk 5 zijn de resultaten beschreven van een studie waarin 
neuropsychologische, klinische en neuroradiologische veranderingen bij 
CADASIL-patiënten tussen de leeftijd van 21 en 35  jaar worden vergeleken met 
dezelfde parameters bij niet-gemuteerde leeftijdgenoten. Het belangrijkste 
resultaat is dat er bij jonge CADASIL-patiënten geen meetbare lichamelijke 
of cognitieve stoornissen aanwezig zijn. Wel komt bij mutatiedragers meer 
migraine met aura voor en bij een klein aantal mutatiedragers zijn er 
aanwijzingen voor TIA’s en (minor) stroke. Alle CADASIL-patiënten hebben, 
soms subtiel, witte stofafwijkingen bij het MRI-onderzoek. Opvallend is dat de 
eerste witte stofafwijkingen ontstaan in de anterieure temporaal kwab. 
In hoofdstuk 6 wordt onderzocht of er verschillen bestaan in de MRI-
afwijkingen die bij jonge CADASIL- en jonge multiple sclerosis-patiënten 
worden aangetroffen. Zowel in klinische als radiologisch opzicht heeft CADASIL 
overeenkomsten met multiple sclerosis en wordt bij veel CADASIL-patiënten 
in eerste instantie de diagnose multiple sclerosis gesteld. CADASIL-patiënten 
hebben signifi cant meer witte stofafwijkingen in de anterieure temporaal 
kwab en subcorticale lacunaire laesies. Ondanks het feit dat multiple sclerosis 
veel vaker voorkomt dan CADASIL moet toch aan de diagnose CADASIL 
gedacht worden bij de aanwezigheid van deze afwijkingen. Met behulp van 
MRI is het mogelijk om al op een jonge leeftijd onderscheid te maken tussen 
CADASIL en multiple sclerosis en kennis van deze verschillen kan het stellen 
van de verkeerde diagnose verminderen.
In hoofdstuk 7 wordt de invloed van het apoE genotype op de ontwikkeling 
van structurele afwijkingen in de hersenen van CADASIL-patiënten onderzocht. 
ApoE is een bekende genetische risicofactor voor het ontwikkel van de ziekte 
van Alzheimer en sporadische amyloid angiopathie. Er is een grote variatie 
in het natuurlijk beloop van CADASIL, echter in CADASIL heeft apoE geen 
invloed op de ontwikkeling van afwijkingen in de hersenen. Daarom moeten 
er andere factoren zijn die verantwoordelijk zijn voor het verschil in beloop 
van de ziekte.
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In hoofdstuk 8 wordt bestudeerd of primair een afname in cerebrale bloedstroom 
of aantasting van de cerebrovasculaire reactiviteit verantwoordelijk is voor de 
ontwikkeling van witte stofafwijkingen en lacunaire infarcten. We laten zien 
dat in CADASIL-patiënten de cerebrovasculaire reactiviteit niet is afgenomen 
maar dat er wel een signifi cante daling is van de cerebrale bloedstroom. 
Aangezien een daling van cerebrale bloedstroom veroorzaakt kan 
worden door wijdverspreide vernauwing van cerebrale bloedvaten lijkt het 
aannemelijk dat bij CADASIL-patiënten vernauwing van cerebrale bloedvaten 
een belangrijker rol speelt bij de ontwikkeling van witte stofafwijkingen en 
lacunaire infarcten dan aantasting van de cerebrovasculaire reactiviteit.
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